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Abstract
Photo-crosslinkable polymeric biomaterials have emerged in the field of biomedical research
to promote tissue regeneration. For example, scaffolds that can be crosslinked and hardened in
situ have been known to make suitable implant alternatives. Since injectable and photocrosslinkable biomaterials offer the advantage of being minimally invasive, they have emerged
to compete with autografts, a current highly invasive method to repair diseased tissue. A series of
novel photo-crosslinkable, injectable, and biodegradable nano-hybrid polymers consisting of
poly(ε-caprolactone fumarate) (PCLF) and polyhedral oligomeric silsesquioxane (POSS) has
been synthesized in our laboratory via polycondensation. To engineer the material properties of
the nano-hybrid networks, varied weight compositions of POSS (ϕPOSS) were combined with
PCLF. The material properties of uncrosslinked and crosslinked PCLF-co-POSS samples were
characterized by gel permeation chromatography, thermogravimetric analysis, dynamic
mechanical analysis, and differential scanning calorimetry. Surface properties were also analyzed
via the water contact angle. From the analysis, we have found that higher weight percentages of
POSS resulted in higher stiffnesses and thermal degradation temperatures, but lower
crystallinities. Further, PCLF-co-POSS (ϕPOSS = 5%, 10% and 20%) samples had higher
wettability, as indicated by smaller water contact angles. The increase in wettability was likely
due to POSS’s ability to enhance porosity. To enhance the study for bone repair applications, the
PCLF-co-POSS (ϕPOSS = 20%) nanocomposite was supplemented with 20% hydroxyapatite (HA)
nanoparticles and formed into disks with smooth and microgrooved surfaces. By tailoring PCLFco-POSS material properties, substrates can be engineered to entice attachment, proliferation,
and differentiation of mouse pre-osteoblastic MC3T3-E1 cells and rat primary aortic smooth
muscle cells, targeting for bone and cardiovascular tissue engineering applications.
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Chapter I. Medical Polymers for Tissue Engineering Applications
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1.1 Background
This project combines the interdisciplinary fields of biomedical engineering and materials
science engineering to develop suitable polymeric biomaterials for bone and cardiovascular
tissue engineering applications. Importance of rehabilitation in both fields is a significant yet
challenging problem to solve. Bone trauma, injury, and disease is debilitating and can lead to a
consequential decreased quality of life by causing pain, inflammation, and restricting movement.
According to the Center for Disease Control (CDC) over 43 million Americans have
osteoarthritis (OA) and it is estimated that by 2030 over 67 million Americans will have the
disease [1]. Further, according to the International Osteoporosis Foundation, (IOF) osteoporosis
affects over 75 million people worldwide, and is partly responsible to the 8.9 million bone
fractures per year worldwide, and can induce up to a 10% total bone loss in patients [2]. Another
topic discussed in this project is the use of polymeric biomaterials to promote aortic smooth
muscle repair caused from cardiovascular disease. According to the CDC, heart disease is the
No. 1 cause of death in America, causing over 600,000 deaths per year and equating to medical
expenses of over $108.8 billion per year [3]. To combat bone and cardiovascular ailments,
research in the engineering of bio-artificial scaffolds has become an essential approach to
enhancing and ultimately rehabilitating these ailments.
Currently the gold standard to heal and regenerate bone and cardiovascular injuries is the
autograft procedure, which is performed by harvesting cells or tissue from an area of the body
and transplanting them into another region in the body of the same individual. Although
autografts have proven to perform well in regenerating tissue and aiding in recovery, serious
limitations are still prevalent. Problems associated with autografts include donor site morbidity,
immunogenic rejection, and highly invasive surgery [4]. To combat the limitations associated
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with autografts, synthetic polymeric biomaterials have been developed with tailorable
mechanical and rheological properties to match site specific implantation. Additionally,
injectable and crosslinkable viscous polymer solutions have been engineered to be cured and
polymerized in situ via redox, thermal, or photo initiation, thereby reducing patient down time
and mitigating the ill effects of highly invasive surgery. In this project, the use of bio-inspired
polymers including poly(ε-caprolactone) (PCL) and polyhedral oligomeric silsesquioxane
(POSS) has been studied to design biodegradable, osteoconductive, and cyto/hemocompatible
substrates for bone and cardiovascular tissue engineering applications.
1.2 Tissue Engineering
Tissue Engineering (TE) is an interdisciplinary branch of engineering and regenerative
medicine which uses natural and synthetic materials to regenerate and rehabilitate damaged cells
and tissues [5]. TE has proven to be successful in the early stages of repair for bone, blood
vessels, cartilage, enamel, and skin. Elementary TE involves cell and tissue culturing techniques
to promote growth and generation of targeted tissues [6]. Important factors to consider in
successful TE practices include cell attachment, proliferation, differentiation, and gene
expression. An advantage of TE is the ability to reduce the need for highly invasive and
dangerous procedures such as autografts [7].

Figure 1.1 Common tissue engineering approaches.
3

Because cells and tissues can be grown in vitro, much research has been devoted to the
use of TE for regenerating various connective tissues, collagen, and organs to create successful
alternatives for autografts. TE applications can be studied via two mechanisms which involve the
regeneration of tissue via natural cells derived from human or animal donors. Alternatively,
tissue regeneration can be promoted from the integration of synthetic materials such as polymers,
metals, ceramics, and composites with various cell and tissue types appropriate for the targeted
rehabilitation site. Further, the latter approach for TE can be further broken down into the subfield known as biomaterials.
The ultimate goal of TE is to maintain, restore, and improve tissue function [8]. To do
this effectively, limitations including cytotoxicity, rejection, and demand need to be addressed.
Although artificial tissues and organs such as tracheas, bladders, and hearts have been developed,
significant problems of immunorejection and incompatibility still remain. In the design of threedimensional TE applications which mainly involve the regeneration of organs, the extracellular
matrix (ECM) is the main component that needs to be examined. Comprised of polysaccharides
and proteins such as collagen, laminin, and fibronectin, the ECM serves as the structural
component for tissues [9]. Type I collagen comprises most of the ECM and is the most abundant
protein in both the ECM and the body [10].
1.2.1 Autografts
Autografts currently provide the best form of treatment for human tissue regeneration.
Autografts are performed by harvesting cells from the same donor that is in need of tissue
reconstruction. Autografts are useful especially for bone grafting procedures since they can
promote both osteoconduction and osteogenesis [11]. However, autografts can bring discomfort

4

to patients since secondary surgery is required to harvest tissue.

1.2.2

Allografts
Allografts are similar to autografts in the fact that tissue is harvested from a donor and

transplanted into the subject of need; however, with allografts the donor is not the subject of
need but rather from another subject of the same species. Allografts offer an advantage over
autografts by eliminating donor site morbidity and additional surgery for the patient.
Nevertheless, allografts are still secondary to autografts because of problems such as immuneincompatibility and disease transmission [12].
1.2.2 Xenografts
Xenografts are similar to allografts by transplanting tissue from a separate donor to the
subject of need; however, the donor in a xenograft will be from a different species, most
commonly derived from bovine. Xenografts are not optimal forms of treatment as they have the
potential to pose serious risks to the subject in need. Risks include cross-species disease
transmission, immunorejection, and bacterial and viral infections [13].
1.3 Cell-Cell/Cell-ECM Interactions
The ECM is an essential scaffold for tissue and organ development as well as, regulation
of cell behavior including cell-cell and cell-ECM interactions. These interactions are imperative
in the control of cell behavior including, the regulation of cell shape, development, migration,
proliferation, and function [9]. Further the cell-cell and cell-ECM interactions can be an essential
indication of whether or not a tissue engineered construct will be biocompatible for separate
individuals. Cell-cell and cell-ECM interactions play a crucial role in ECM control and
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regulation. For example, cell-ECM interactions regarding chondrocytes and the ECM have
shown that chondrocytes, because of their multitude of receptors can influence ECM homeostatic
balance therefore, affecting the ECM signaling system [14]. Essential approaches that TE
depends on are successful cell and tissue migration, proliferation, and differentiation of which
are all influenced by cell-ECM interactions [15,16]. Cell-ECM interactions are capable of
regulating cell functions via receptor mediated signaling by triggering integrin and ligand
binding interactions. For example, osteoprogenitor cells and osteoblasts have been shown to
significantly express the α5β1 integrin thereby, the design of a biomaterial aimed to enhance the
expression of the α5β1 integrin is an important factor to consider for bone TE applications [12].
Further, smooth muscle cells tend to express αv containing integrins, especially α vβ3 during
angiogenesis (e.g., formation of new blood vessels) [17]. Because of cell-ECM interactions,
receptor mediated signaling is able to control vital physiological pathways and regulate growth
factors to stimulate cell proliferation and adhesion to ECM scaffolds for successful TE
applications.
Although the ECM is responsible for cell signaling and regulation within
microenvironments, the ECM is also needed to fulfill further roles of ensuring structural integrity
for newly formed tissue [18]. ECM for successful TE applications should have the desired
mechanical properties to support itself and the surrounding forces acting on it. The ECM has the
ability to control specific transduction pathways for attachment, proliferation, and differentiation;
however, selectively activating targeted pathways still remains unsolved thus, posing challenges
for immunogenic compatibility. An important pathway influenced by cell-ECM interactions is
the mitogen-activated protein kinase (MAPK) pathway. MAPK is responsible for the regulation
of growth factors and cell phenotype, both essential to TE. MAPKs are protein kinases which
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regulate three amino acids including serine, threonine, and tyrosine [19]. MAPK can control
growth factors and induce cell signaling for cell division by their ability to act as an “on/off”
switch. This is accomplished by MAPK ability to add phosphate groups to neighboring proteins,
therefore activating or deactivating specific growth pathways [20]. Studies have demonstrated
that MAPK activation plays a role in regulating osteogenesis and promoting bone growth.
Mouse pre-osteoblastic MC3T3-E1 cells cultured on stiff poly ethylene glycol (PEG) substrates
have shown to increase alkaline phosphatase (ALP), osteocalcin (OCN), and bone sialoprotein
(BSP) gene expression levels as well as, significantly increase MAPK activity thereby,
enhancing the ability to regenerate bone tissue [21]. Although MAPK is critical to cell growth
and proliferation, factors to promote significant upregulation of MAPK activation has proven to
be a problem as this can lead to tumor and malignancy formation.
1.3.1 Growth Factors
Growth factors also play a critical role in regulating cell growth, proliferation, and
survival necessary for TE. Growth factors are polypeptides that signal cells to respond to
different biological environments [22]. Growth factors interact with the signaling components of
the ECM such as, ligands and growth factor receptors to ensure correct cell function and signal
transduction for regenerating tissue in different locations. Various growth factors play a vital role
in the development, inhibition, and stimulation of specific tissues. For example, certain growth
factors have the ability to entice growth of blood vessels, bone, cartilage, and skin. However,
downregulating and upregulating signal transduction induced by growth factors, which is
necessary for proper cell function, still remains a challenge. Further, specific growth factors can
be delivered to the site of interest to improve wound healing, functional tissue development, and
hormone delivery [23]. In order to deliver growth factors to site specific locations to promote cell
7

attachment and proliferation, polymer carriers with incorporated growth factors have been used
to sustain the release of the bioactive molecules as the polymer degrades over time [24]. Table
1.1 lists common growth factors for tissue regeneration.

Table 1.1Common growth factors and their functions used in TE applications.
Growth Factor

Function

Angiopoeitin

Growth of veins and arteries

Bone Morphogenetic Protein (BMP)

Promote bone and cartilage growth

Epidermal Growth Factor (EGF)

Regulate cell growth, proliferation, and
differentiation

Fibroblast Growth Factor (FGF)

Regulate wound healing

Growth Differentiation-8 (GDF-8)

Regulate skeletal muscle growth and
differentiation

Insulin-like Growth Factor-1 (IGF-1)

Regulate glycogen synthesis in osteoblasts

Platelet-derived Growth Factor (PDGF)

Development of blood vessel formation

Transforming Growth Factor Alpha (TGF-α)

Activates pathways for cell proliferation and
differentiation

Transforming Growth Factor Beta (TGF-β)

Activates pathways for cell proliferation and
differentiation

Tumor Necrosis Factor (TNF)

Regulate apoptosis

Vascular Endothelial Growth Factor (VEGF)

Regulate blood vessel formation

1.3.2 Growth Factors and Cancer
Although growth factors are imperative for the regulation of cell growth, proliferation,
differentiation, and migration, which are all necessary for the regeneration and formation of new
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tissue, growth factors have been shown to contribute to malignancy formation and cancer
progression. Specifically, growth factors promote cancer progression by influencing cell invasion
across tissue barriers, clonal expansion, and colonization of cells in distant niches [25].
Oncogenic mutations result in uncontrollable growth factor stimulation thereby, promoting
tumorigenesis [26,27]. For example, overexpression of genes that release IGF-1 has been linked
to increased risk of colorectal cancer as well as, increased tumor size [28]. Further, increased
levels of IGF-1 have been shown to stimulate breast cancer cell proliferation, because IGF-1 and
IGF-1 receptor (IGF-1R) signaling pathways are upregulated by breast cancer tumors, induced
from mutations in breast cancer susceptibility genes 1 and 2 (BRCA1/2) [29].
1.4 Biomaterials
Biomaterials encompass the use of synthetic materials such as metals, ceramics,
polymers, and composites for biological integration. Biomaterials science is closely related to TE
and requires multidisciplinary study from medicine, biology, engineering, chemistry, and
physics. Advantages of synthetic biomaterials are less invasive surgeries, faster recovery; and
tailorable mechanical, chemical, and topographical properties to match site specific applications.
The ultimate goal of biomaterials is to improve physiological function, aid in healing, and
replace living tissue as an implant. Biomaterials have emerged in the field of regenerative
medicine and have proven to be successful scaffolds to repair cells, tissues, and organs [30].
Biomaterials can be defined as a nonviable materials used in a medical device aimed to be
integrated into biological systems [31]. Human applications for biomaterials include a wide
variety of targeting such as joint replacements, drug delivery, nerve regeneration, and vascular
stents. Table 1.2 represents the current commonly used biomaterials and their applications.
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Table 1.2 Common biomaterials used and the biomedical application for each material [32].
Tissue Engineering Application

Biomaterial

Joint Replacement

Cobalt-chromium, Titanium, Ti-Al-V,
Stainless Steel

Bone and Dental Cement

Poly(methyl methacrylate) (PMMA),
Hydroxyapatite (HA)

Dental Implant

Titanium, Ti-Al-V, polyhedral oligomeric
silsesquioxane (POSS), HA, Calcium
Phosphate

Ligament

Dacron

Blood Vessels

(PCL), Polycarbonate Urea (PCU), Teflon,
POSS, polyurethane (PU)

Kidney

Cellulose, Polyacrylonitrile (PAN)

Lungs

Silicone, Polytetrafluroethylene (PTFE)

Contact Lenses

Si-acrylate, PMMA,
Polyhydroxyethylmethacrylate (PolyHEMA)

Corneal Regeneration

Hydrogels, Collagen

In order to engineer appropriate biomaterials for suitable use in human subjects, the
designed material must proceed through a wide variety of tests and regulatory standards before
being approved. In order to understand whether or not a biomaterial will be suitable for
implantation, the material must first be in a purified and sterilized form and be an acceptable
substrate for culturing cells, and enticing cellular adsorption, proliferation, and differentiation
[32]. Currently the study of biomaterials focuses heavily on synthesizing and characterizing
materials, as the chemical composition, mechanical, and, rheological properties of the material
will allow for prior understanding of its use as a viable biomaterial before physiological and
biological experiments are carried out. When a biomaterial is designed, precise reactions with
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specific proteins and cells can be tailored for specific applications thereby, making the design
process imperative for ensuring proper cell-material interactions [32]. Further, biomaterials must
possess an important trait of being biocompatible within the desired biological system. This is a
critical step in biomaterial fabrication and implantation since incompatible implants are liable to
cause severe harm and injury to patients including immunorejection, inflammation, infection,
surgical defects, and impaired healing [33]. Since biocompatibility is highly regulated, all
materials intended for medical implantation must meet advanced standards and undergo testing
regulated by the International Organization for Standardization (ISO). Specifically, to test for
biocompatibility, ISO 10993 must be performed on the desired material aimed for biomedical
use [34]. The ISO 10993 standard tests for a wide variety of material interactions including,
cytotoxicity interactions with blood (hemocompatibility), carcinogenicity, and risk management
assessments [35].
1.4.1 Polymeric Biomaterials
Polymers are among the most commonly encountered materials throughout daily life and
have many important applications for everyday use. More importantly, polymers have the ability
to be suitable biomaterials as they can be easily modified to fit specific needs of the body.
Polymers are viable components for engineering both two-dimensional and three-dimensional
scaffolds. The development of polymer scaffolds has recently had a significant impact on the
field of TE by providing cells and tissues favorable environments for growth and sustainability.
In the design of polymer scaffolds for TE applications, cellular cues used to promote
adsorption and differentiation are important parameters to consider. For example, polymer
scaffolds with variable surface properties can provide stem cells with physical cues such as
stiffness, size, and shape to determine what type of primary cell they will differentiate into.
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Specifically, mimicking the microenvironments of site specific areas for targeted regeneration
can allow for stem cell differentiation needed for in vitro cell and tissue growth, which is
essential for repair [36]. The table below lists current commonly used Food and Drug
Administration (FDA) approved biomaterials.

Table 1.3 Commonly used and FDA-approved polymers and their applications.
Polymeric Biomaterial

Application

PEG

Cartilage, bone tissue, drug delivery, and gene
therapy

PCL

Smooth muscle and bone tissue

Dacron® Polyethylene Terephthalate

Vascular grafts, Infection resistance

(PET)

Polydimethylsiloxane (PDMS)

Sensing and cell seperation

Poly(p-phenylene oxide) (PEO)

Biomimetic, cartilage, and bone tissue
engineering
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Table 1.3 Commonly used and FDA-approved polymers and their applications. Continued.
Polymeric Biomaterial

Application

poly(lactic-co-glycolic acid) PLGA

Skin grafts, wound healing, and bone repair

PTFE

Catheters, sutures, and cosmetic surgery

PMMA

Contact lenses, bone cement, and dental
prosthetics

To further regulate cell behavior, polymers with tunable topographical, mechanical, and
chemical properties designed to promote specific cell behavior can be categorized as smart
biomaterials [37]. Polymeric biomaterials can serve many different functions from repairing and
replacing tissue to being used for drug and gene therapy [38]. Recently, controlling the
biodegradation rate of biopolymers has become useful for allowing cells and tissue to grow on
substrates and form mechanically stable networks thereby, allowing the polymer to degrade over
time while leaving only the newly formed tissue. Common biodegradable polymers that have
proven to be successful when interfaced with human tissue include PCL, PPF, PEG, PLGA, and
poly(L-lactic acid) (PLLA). Further, novel biomaterials have been developed to possess both
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biodegradable and injectable properties which can allow for less invasive surgical procedures.
Injectable and biodegradable polymers are typically cohesive and gel-like solutions designed to
be injected and crosslinked in situ [38]. Many of these polymers are thermogelling diblock and
triblock copolymers which take advantage of their ability to be hardened via temperature
differences inside and outside the body [39]. Injectable polymers can also be photo-crosslinked
and hardened in situ with ultraviolet (UV) light. Photo-crosslinkable polymers have shown
promise for applications in bone, dental regeneration, and vascular grafts.
1.4.2 Protein-Material Interactions
Proteins are considered natural polymers and are categorized into four different stages of
structure including primary, secondary, tertiary, and quaternary. Proteins are large biomolecules
comprised of a sequence of twenty amino acids, determined by the DNA of the cell. Proteins are
responsible for many actions in the body such as, transporting molecules, replicating DNA, and
regulating hormones. Protein-material interactions are an imperative aspect to consider when
designing biomaterials for implantation. Protein-material interactions are responsible for
determining whether or not a biomaterial will be biocompatible [40]. When materials are
implanted into a physiological system, a protein monolayer is formed around the material (e.g.,
stent, catheter, joint replacement, or TE scaffold) within a matter of minutes. It is understood that
when cells are cultured onto foreign synthetic surfaces that the actual cells are not in direct
contact with the molecular structure of the material, but rather the cells attach onto the
monolayer of proteins. When materials are selected for human applications, the specific material
for use is not bioactive. The bioactivity of the material is determined by the ability of proteins to
adsorb to the surface of the material [40]. The proteins adsorbed to the surface of the biomaterial
are responsible for controlling the action of cells and tissues. Techniques to influence protein
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adsorption to material surfaces can be achieved by surface modification and grafting techniques.
By exposing proteins to various functional groups, protein adsorption can be altered. For
example, the use of methyl (-CH3), hydroxyl (-OH), amine (-NH2), and carboxylic (-COOH)
groups can be used to affect protein and cell behavior [41]. However, there is still an issue in
controlling the protein adsorption behavior to influence cell activity. Table 1.4 lists the effects on
cells of each functional group described above.
Table 1.4 Properties of each functional group and the effect that it has on protein and cell
interactions [40].
Functional Group

Properties

Effects

- CH3

Neutral; Hydrophobic

- OH

Neutral; Hydrophilic

- NH2

Positive; Hydrophilic

-COOH

Negative; Hydrophilic

Promote leukocyte adhesion
and phagocyte migration
Increases osteoblast
proliferation
Increases myoblast
proliferation, and
differentiation of osteoblasts
Increases affinity for albumin
and fibronectin

1.4.3

Cell-Material Interactions
Cell-material interactions are a fundamental but critical topic in biomaterials research.

Similar to, and dependent upon protein-material interactions, cell-material interactions play a
large role in determining specific cues for cell influence and behavior [41]. Materials engineered
with altered surface properties by micropatterning techniques to induce features such as
microgrooves, pores, and channels have been used to improve cell attachment and density. As
discussed earlier in protein-material interactions, when cells attach to the material surface they
are not in direct contact with the material surface, but rather attached to the proteins adsorbed to
the surface, therefore the ability to influence protein adsorption onto the substrate is critical [40].
15

Another important aspect to consider for proper cell attachment and enhanced cell-material
interactions are focal adhesions (FAs). FAs are complex organelles comprised of over 150
proteins [42]. Since FAs are located at the interface between the cytoskeleton and the ECM,
these proteins are responsible for the cell attachment [42]. In turn, FAs serve to anchor the cells
to biomaterial surfaces.
1.5 Conclusion
As reviewed above, the integration between TE and biomaterials has allowed for the
improvement of interfacing synthetic materials with physiological systems. The use of
biomaterials for TE applications has proven to be successful in the advancement of biomedicine
by improving the understanding of cellular responses to implanted materials. Numerous
techniques for polymeric biomaterials have been developed to guide cell behavior and enhance
cell migration, proliferation, and differentiation, which are essential to regenerative medicine.
Specific techniques used to improve the viability of biomaterials include the uses of
biodegradable, injectable, and photo-crosslinkable polymer systems. By understanding the
interactions between proteins, cells, and biomaterials, the engineering of novel polymeric
systems can be tailored for specific needs and continue to improve regenerative medicine.
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Chapter II. POSS-containing Polymer Nanocomposites for Tissue Engineering
Applications: A Literature Review
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2.1 Introduction
The emerging application for nanomaterials in biomedical research has become a
particular area of interest for engineers and scientists. A nano cage-like molecule known as
polyhedral oligomeric silsesquioxane (POSS) has recently become a nanomaterial of interest for
its promising benefits in developing tunable biomaterials for tissue engineering applications. In
the field of biomedical research, interdisciplinary collaboration has become commonplace and
essential to the advancement of healthcare. POSS nanomaterial research has the ability to
coalesce the work of several engineering and science disciplines such as biomedical engineering,
materials science, nanotechnology, and biotechnology. Since POSS is typically used to form
nano-hybrid polymeric networks and copolymers, the involvement of material science and
organic chemistry is imperative. Additionally, since POSS copolymers can be formed into
biomaterials such as hydrogels, thin disks, and injectable molded scaffolds; biomedical engineers
also play a large role to integrate novel polymer constructs into biological systems, thereby
facilitating potential human use. Originally, POSS was developed by the United States Air Force
for aerospace engineering purposes. Thanks to its impressive material properties, this
nanomaterial has been introduced into biomedical research [1-5]. The small diameter (1.5 nm)
and innate ability of POSS to promote material integrity of polymers has demanded the interest
of many researchers, and is emerging as an integral aspect to improve polymeric biomaterials for
biomedical research [6]. Further, using POSS in polymer systems allows for specific tailoring of
biomaterials for bone, cardiovascular, dental, and neural tissue engineering applications. Also the
fact that POSS does not evoke a significant immune response or induce cytotoxicity when
implanted makes it an ideal additive to proven biomaterials [7]. Attributes of POSS include the
ability to slow biodegradation time therefore, allotting more time for cells to proliferate and

23

attach onto the surfaces [8, 10]. Also since POSS can be copolymerized with fumarate containing
polymers such as poly(ε-caprolactone fumarate) (PCLF) and poly propylene fumarate (PPF),
these polymer systems tend to promote a favorable environment for cells, as fumarate is a natural
compound found in mammalian cell metabolism [11]. Additionally, when POSS-containing
nanocomposites incorporate fumarate, the rate of biodegradation becomes less of a problem as
the body can easily excrete these compounds as waste. Because of the ease of excretion and
enhanced biocompatibility, surgical patients would be provided with more comfort and less
downtime, as the need for additional surgeries would be diminished [12-15]. Throughout this
chapter we will discuss several biomedical applications of POSS but, more specifically we will
be reviewing the mechanical and rheological properties of POSS in addition to using POSS for
bone, cardiovascular, and dental tissue engineering applications. From the review we will be able
to showcase the synergistic effects that POSS displays as being both biocompatible and
osteoconductive from cell study evidence.
2.2 Properties
2.2.1 POSS Properties
It is widely known that increasing POSS loading in a polymer system allows for
enhancement and control of material properties, thus making POSS a viable component for
anisotropic tissue properties. By varying the weight percentage of POSS, specific polymers can
be tailored in order to satisfy variable in-situ microenvironments, and therefore ultimately
leading to the creation of an implant with increased biocompatibility. As stated earlier, POSS is a
nano-scale oligomer with a cage diameter of 1.5 nm [12]. POSS is comprised of several Si-O
bonds which are responsible for the cage-like structure. Two factors can explain the ability of
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POSS to strengthen polymers. Firstly, the nature of short silicon and oxygen bonds require high
energies to be broken (Figure 2.1). The property of short Si-O bonds in POSS also contributes to
a slower degradation time [15,16].

Figure 2.1 General structure of POSS.
Figure 2.1 is the general structure of POSS which contains several Si-O bonds with R
groups attached to each silicon atom. It is evident in the figure that the assembly of Si-O bonds is
the backbone of the cage-like structure. Since POSS has short Si-O bonds, significant energy is
required to break the bonds therefore, enhancing POSSs ability to promote material integrity and
strengthening properties as well as, improving chemical and thermal stability [17-20]. Moreover,
these short bonds are a key attribute of POSS, which allows it impose slower biodegradation
when integrated into degradable polymer networks [17,21-23]. Additionally, POSS is able to
strengthen polymers because of the fact that it has the ability to increase crosslinking density in
polymer systems. Specific POSS molecules that are known to increase crosslinking density
significantly include methacryl, isobutyl, and tris norbornenylethyl POSS. However, not all types
of POSS are able to increase crosslinking density, and in some instances POSS molecules such
as, norbornenylethyl POSS decreases crosslinking density [24]. Cross-linked polymers are
stiffer, and thus are desirable for tissue scaffolds subjected to excessive compressive and tensile
forces, such as bone grafts [25-28]. When designing scaffolds for various applications, it is
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imperative to understand that POSS loading affects material stiffness and thermal and chemical
stability [29].
2.2.2 POSS with Variable Functional Groups
Table 2.1 POSS varieties and uses.
Full Name

Structure

Uses

Isobutyl POSS

R=

Porogen

Isooctyl POSS

R=

Porogen

Cyclopentyl POSS

R=

Surface
Modifications

Cyclohexyl POSS

R=

Surface
Modifications

Methacrylate isobutyl POSS

R1=

Increases Tg

R2-8=

26

Table 2.1 POSS varieties and uses. Continued.
Full Name

Structure

Uses

Methacrylate ethyl POSS

R1=

Increase
hydrophobicity
and toughness

R2-8=

Methacryl Isobutyl POSS

R1=

Increase
hydrophobicity
and toughness

R2-8=

Aminopropypisobutyl POSS

R1=

Grafting agent

R2-8=

Octa-Aminopropyl POSS

R=

Grafting agent

Octa-Aminophenyl POSS

R=

Grafting agent
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Table 2.1 POSS varieties and uses. Continued.
Full Name

Structure

Uses

Octa-isobutyl POSS

R=

Porogen

Octa-

Cure accelerator

R=

epoxycyclosexyldimethylsilyl
POSS
Octa-glycidyldimethylsilyl

R=

Cure accelerator

Octa-Maleaic Acid POSS

R=

Peptide/Amino
acid
dispersion

Octa-Ammonium POSS

R=

Drug delivery
and dendrimers

Octamethacryl POSS

R=

Increase Tg

Octa-methyl POSS

R=

Improve
hydrophobicity
Crosslinking
agent

POSS

Octa-vinyl POSS
R=
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Table 2.1 POSS varieties and uses. Continued.
Full Name

Structure

Uses

Octa-3-hydroxy-3-

R=

PU crosslinker
and adhesion
promotion

methylbutyldimethylsiloxy
POSS
R=
1,2-propanediolisobutyl

Increase
strength and
toughness

POSS
Trifluoropropyl POSS

R=

Reduce surface
energy

Norbornenylethylethyl POSS

R=

Toughening
agent

2.2.3 Effects of POSS on Crystallinity
POSS has been shown to act as a nucleating agent to promote or decrease crystal and
spherulite formation for several nano-hybrid networks, therefore increasing crystallization rates
and temperatures [32]. Advantages of nucleating agents include enhanced physical and optical
properties such as stiffness, toughness, heat distortion, hardness, and clarity [32-37]. Studies
have revealed that overall crystallinity decreases while POSS occupies a higher weight
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percentage of the crosslinked nanocomposite. Specifically polypropylene (PP) and octa-vinyl
POSS composites have proven that POSS increases crystallization rate and temperature while
decreasing total crystallinity when compared to PP alone. Further supported from this study was
that POSS greatly reduced the amount of spherulite formation of PP because of the
heterogeneous nucleating effect of POSS [38,39].
2.2.4 POSS Thermal Properties
POSS has the ability to promote thermal stability of a nanocomposite. When analyzing
thermal degradation of a polymer via thermogravimetric analysis (TGA), the addition of POSS
has proven to increase total weight percent residue, which is due the silicon’s ability to increase
the inorganic phase [40-43]. Thermal degradation has been studied on several functionalized
POSS molecules including octahydride-POSS, polyvinyl-POSS, methyl-POSS, isooctyl-POSS,
and isobutyl-POSS. From the studies, isooctyl-POSS and isobutyl-POSS degrade at the highest
temperatures ranging from 307 ° to 372 °C respectively, while octahydride-POSS had the lowest
degradation temperature at 157 °C [44]. POSS also improves thermal stability by protecting the
surface layer of a polymer matrix and restricting the diffusion of oxygen into the matrix. When
POSS-containing nanocomposites are heated, POSS degrades first and evolves into a superficial
ceramic-like protective layer over the polymer [45-48]. Because POSS can decrease heat transfer
by acting as a protective layer, POSS has also been used as flame retardants [49-53].
Furthermore, differential scanning calorimetry (DSC) has been used to show that the glass
transition temperature (Tg) increases in correlation to the increase of POSS aggregates in
polymer networks [54-60].
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2.3 Biomedical Applications
2.3.1 Orthopedic Applications
The fact that POSS can be used to tailor and enhance material properties has sparked
interest in its use for bone-tissue-engineering applications [61-64]. POSS can be used to generate
autologous bone grafts for individuals with recent bone trauma, injuries, or osteoporosis. In order
to examine the material properties effected by POSS, copolymers and polymer blends such as,
PPF-co-POSS, PCLF-co-POSS, poly(ε-caprolactone) triacrylate (PCLTA)/POSS, polyethylene
glycol (PEG)/POSS, and polyurethane (PU)/POSS were first synthesized via polycondensation
with varied weight percentages of POSS, then photo-crosslinked. Once crosslinked, the samples
were then swelled in organic solvents such as methylene chloride or acetone then dried for
several days in a vacuum. Because POSS can induce porosity onto the surfaces of polymer
systems, porosity variations can be analyzed via imaging and the use of the sessile drop
technique. Surface imaging techniques are typically analyzed via scanning emission microscopy
(SEM) and atomic force microscopy (AFM). It is known that an increase in POSS loading will
induce a higher surface porosity thereby, increasing surface wettability [65,66]. Advantages of
polymer substrates engineered with POSS include, the ability for the polymer networks to entice
cell differentiation, elicit a promising surface for protein and cellular adsorption and, promote
osteoconductivity, and gene expression [19,67-70]. Furthermore, POSS nano-composites tend to
induce porosity with a pore diameter ranging from 1.41 to 3.10 nm, which makes simulating the
natural porous structure of bone tissue less of a challenge and thereby, making POSS a suitable
additive in the development of a bone mimetic material [64]. Since POSS-containing polymer
systems can simulate the natural environment of bone as well as, stimulate bone regeneration, it
is ideal to use as a scaffold for heterologous bone grafting [64-68]. Further, POSS performs well
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in the ability to easily control and enhance the material properties of polymer networks for
anisotropic bone tissue [26,67]. Because POSS has an impact on material properties as well as,
inducing surface porosity, several research ideas have been assimilated based upon using POSS
monomers in the development of copolymers aimed to entice bone growth and promote
regeneration. For example, osteoconductive POSS has been studied to create injectable and
crosslinkable polymer resins that can be cured via UV light in situ [71,72]. In the treatment of
spinal injuries, the use of POSS is important in the synthesis of a copolymer because it not only
allows for a tunable polymer network with desired material properties but, also allows for a
polymer that can be hardened in situ thus, being less invasive to surgical patients (Figure 2.2). A
spinal fracture contains many bone fragments which contribute to inflammation, pain, restricted
movement, and slow recovery time.

Figure 2.2 A spinal fracture with several separated bone fragments within the vertebra.
As shown above, it is evident that an osteoconductive and, photo-crosslinkable polymer
could offer desired healing benefits for patients by providing a possible outpatient spinal surgery.
Because of the minimally invasive nature of this procedure, faster recovery would be expected.
With regards to treating the injury, POSS would be a viable component in the engineering of a
copolymer with tailorable mechanical characteristics that can exhibit similar mechanical
properties of bone such as stiffness, toughness, and elasticity. In particular, stiffness and
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toughness are imperative parameters to consider when treating bone related spinal injuries, since
the spine is responsible for being able to withstand immense yet constant forces such as
compressive, tensile, torsional, and external forces. Typical spinal injuries are known to occur at
compressive forces exceeding 1720 N [72]. Further, evidence has shown that spinal injuries
related to torsion tend to occur at a torque of 13.6 N·m and a rotation of 114 ° [72]. With these
pre-factors in mind, the tailorable effects of POSS would be highly desired in the design of a
copolymer that showcases strong material properties by being able to withstand high loading
forces yet, possess high enough elastic properties to account for spinal torsion. Another
advantage of POSS is to simulate the characteristics of hydroxyapatite [HA, Ca10(PO4)6(OH)2],
which is the main mineral found in bone and teeth [73,74]. HA is a common biomaterial used
since its surface properties display porosity and its structural properties exhibit hardness, which
is essential to bone. However, HA tends to be very brittle and cannot be applied to a load-bearing
site therefore; alternatives have been desired. Research has shown that the use of POSS could be
a feasible replacement to HA. The use of POSS with bio-inspired polymers such as PEGF,
PCLF, or PPF is excellent for generating bone grafts, as these nano-composite networks would
be both osteoconductive and offer low toxicity to cells [74]. Studies have shown that PEG or
PCL/POSS scaffolds are a great choice to use for the promotion of bone growth and bone grafts,
as this particular scaffold has an uncanny ability to promote osteoblast cell differentiation and
proliferation [73-75]. Specific cell lines that have responded well to POSS composite scaffold
have been the mouse pre-osteoblastic MC3T3-E1 cells. Studies regarding the use of fumarate in
POSS-containing nanohybrid polymer networks have proven to maximize MC3T3-E1 cell
functions including proliferation, differentiation, and gene expression [76-78].
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Additionally, studies have examined the use of PEG and PCL with POSS to form
copolymers synthesized via polycondensation at room temperature under nitrogen for 12 h.
Specifically, a polymer blend consisting of PEG or PCL/POSS was evaluated on the ability to
promote pre-osteoblastic MC3T3-E1 mouse cell proliferation in comparison to a PCL/PEG
copolymer and PCL alone (Figure 2.3).

Figure 2.3 Proliferation of MC3T3-E1 cells cultured on the surface of PCL/PEG3.4k-POSS,
PCL/PEG8.0k-POSS, and PCL/PEG8.0k electrospun scaffolds as a function of the time in
culture [78].
Further, the polymer blend showed promising cell proliferation as the number of cells on
the POSS substrates was far greater than PCL alone. This is because of POSS siloxanes have the
ability to induce higher free surface energy and stimulate higher cell attachment [78]. Studies
have further suggested that the use of POSS as a material strength enhancer to induce surface
stiffness tends to promote mouse pre-osteoblastic MC3T3-E1 cell proliferation and
differentiation, as the cells have been shown to favor stiffer surfaces with a modulus of elasticity
(E) of 1GPa rather than a softer surface where (E) is 1KPa. Similar results have been gathered
where the same MC3T3-E1 cell line was cultured on PCLTA-POSS substrates where (E was 420
or 14 KPa) [69].
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Figure 2.4 Cell attachment and proliferation on photo-crosslinked PCLTA-POSS substrates with
varied mechanical properties. (a) Tensile moduli, (b) normalized cell attachment, (c)
Fluorescence images of the cells stained with rhodamine-phalloidin (red) and DAPI (blue).
Shown in Figure 2.4 above, it is evident that an increase in POSS loading increases the
overall average tensile moduli in PCLTA matrices. Moreover, normalized cell attachment and
proliferation is enhanced with an increase in POSS composition. It is evident from the two
studies that POSS looks to be a promising nanomaterial for biomaterial scaffolds to promote
bone tissue regeneration.
Finally POSS has also been studied for implant coatings. More specifically POSS has
been considered as an additive into polymer hip implants. Since hip implants are inserted into the
femur and are always in contact with the surrounding bone, the osteoconductive and
biocompatibility properties of POSS have been favored in this area [79].
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2.3.2 Cardiovascular Applications
Vascular engineering is an area of research aimed at integrating living cells, biomaterial
scaffolds, and even animal cells to formulate biocompatible smooth muscle cell (SMC) tissue for
organ repair and replacement [5]. The goal of cardiovascular tissue engineering is to ultimately
entice SMC tissue to grow in human subjects without eliciting significant immune response or
rejection. To create an effective polymer that simulates the environment of the cardiovascular
system, several materials have been studied including POSS. In addition to being biocompatible
and providing satisfactory cell-material interactions, the use of POSS in the cardiovascular
system provides many advantages to polymer systems, such as the enhancement of mechanical,
chemical, and thermal properties, which includes viscoelasticity, calcification resistance, and
wettability [8,17,80-83]. Furthermore, since POSS has been shown to increase stiffness and
rigidity, it has been used for coatings in arterial stents and drug eluting stents. The use of POSS
in a polycarbonate urea (PCU) copolymer has demonstrated that POSS is not only
hemocompatible with vascular SMCs but also exhibits anti-inflammatory properties and evokes
negligible immunoreactivity [83-85]. Also evidence from thromboelastography (TEG) has
shown that POSS exhibits anti-thrombogenic properties when implanted into vascular
architecture therefore, amplifying the effectiveness of drug eluting stents [83]. Surface
topography analysis such as (AFM) and transmission emission microscopy (TEM) have
confirmed that POSS nanocomposite rich surfaces have the ability to repel both platelets and
proteins responsible for stenosis formation [85]. Due to the antithrombogenic and bio-inert
nature of POSS, it can be used further in stent therapy in order to aid in the delivery of blood
thinning medications to an obstructed area.
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Studies have indicated that PCU-POSS enhanced cell capture of endothelial progenitor
cells (EPCs) on POSS containing substrates used for cardiovascular stent applications while
maintaining non-cytotoxic to surrounding cells. Recent studies have shown that PCU-POSS has
been biofunctionalized onto the polymer surface with anti-CD34 by the use of fumed silica
(Figure 2.5).

a

b

Figure 2.5 EPC capture on PCU-POSS substrates and tricalcium phosphate (TCP) positive
control [82].
As shown above, it is evident that the biofunctionalized PCU-POSS substrate enhances
EPC adhesion. The use of PCU-POSS is intriguing in its ability to promote in situ
endothelialization thus, making this substrate an exceptional design for hemocompatibility, long
term viability, and vessel restoration [82].
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POSS-PCU polymer substrates have also proven to be successful scaffolds for its use in
the development in heart valve leaflets because of the superior ability of POSS to enhance
mechanical properties such as tensile strength and strain when compared to conventional PU
substrates.

Table 2.2 Mechanical properties of commercially available PU-based polymers [86].
Polymer
Elastane ® (PEU)
Chronoflex ® C
Elasteon ™
POSS-PCU

Hardness
(Shore A)
85
80
75-90
84

Tear Strength
(N mm-1)
55
45
50-80
50 ± 1.2

Tensile Strength
(N mm-2)
48.3
37.9-45.5
20-30
53.6 ± 3.4

Elongation at
Break (%)
570
400-490
500-750
704.8 ± 38

2.3.3 Dental Applications
Not only is POSS a great promoter of SMCs and bone tissue growth but, it is also used in
the dental field to restore enamel. POSS has become very popular in dental research for the
prevention of tooth decay as well as, dental regeneration [87]. This field is quite similar to
research with regards to bone, since HA is also the main mineral found in teeth [88]. An
interesting attribute of POSS which inspires researchers to use this material for dental research is
the very small size of the POSS particles. POSS particles are typically 1.5 nm in diameter thus,
making these particles significant vehicles to fill micro-cracks and pores within teeth when
combined with polymethylmethacrylate (PMMA) and methylmethacrylate (MMA) matrices [8892]. HA naturally contains 2.4 nm diameter tubules throughout its structure, which can allow for
foreign debris and bacteria to infiltrate these small spaces and cause decay to the tooth and
surrounding bone. POSS molecules smaller than 2.4 nm have been used to infiltrate the HA
tubules and act as a shield to food particles and harmful bacterial which promote decay [93].
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Another advantage to using POSS for dental applications is because of the fact that PMMAPOSS and MMA-POSS resins can be photo-crosslinked easily and cured with UV light thereby,
allowing for fast in office procedures for patients. Studies have shown that POSS containing
MMA and PMMA nanocomposites have proven to be suitable materials for dental implants and
resins because of the increased compressive strength and shear stress of the dental filler [94, 95].
2.3.4 Drug Delivery
Additional biomedical uses for POSS have been studied including revolutionary novel
drug delivery applications. POSS has proven to be a successful drug delivery carrier because of
its ability to be easily functionalized and biologically inert [96, 97] POSS particles have shown
promise for first generation poly(amidoamine) (PAMAM) dendrimer formation because of their
nanocage-like structure. Dendrimers are a topic of interest for anti-cancer, diabetic, neural and,
ocular regeneration, and tissue engineering applications [98-101]. Advantages of dendrimers
include their ability to encapsulate therapeutic drug agents thus, protecting them from
degradative enzymes and chemical breakdown. Moreover, dendrimers have the ability to deliver
site specific drugs because of external chemical functionalization for direct cell targeting.
Evidence has shown that self-assembled PAMAM-POSS based dendrimers loaded with insulin
improved the dispersion and diffusion of insulin through cell membranes. Further evidence
showed that the PAMAM-POSS dendrimer cores protected insulin for up to two hours [102].
PAMAM-POSS dendrimers have also been self-assembled into bilayers in which, anti-cancer
drugs and folic acid have been loaded into for ligand binding and receptor mediated endocytosis
[103].
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2.3.5 Common POSS Nano-Hybrids for Tissue Engineering Applications

Table 2.3 Commonly used POSS-containing polymer nanocomposites for tissue engineering
applications [104,105].
POSS Blends and Copolymers

Tissue Engineering Application

PPF-co-POSS

Bone

PEG-POSS

Bone/Vascular

PCL-POSS

Bone/Vascular

PU-POSS

Bone/Vascular

PCU-POSS

Vascular

PLLA-POSS

Vascular

PEG-co-POSS

Bone/Vascular/Drug Delivery

PVA-POSS

Drug/Gene Delivery

POSS-PEG-PLA

Drug/Gene Delivery

POSS-Methacrylate

Dental

POSS-MMA

Dental

POSS-PMMA

Dental

2.4 Conclusions
Throughout this review we have suggested the various biomedical uses and benefits
associated with POSS. After examining the ability of POSS to be used in conjunction with many
polymers to enhance material properties while still providing a biocompatible substrate, we can
conclude that POSS is an effective nanomaterial for cancer therapy, drug delivery, and tissue
engineering applications. Furthermore, since POSS has been shown to be osteoconductive and a
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suitable replacement to HA, POSS is ideal to use for bone and dental regeneration. Ultimately,
the use of POSS for biomedical research has become an interesting topic due to the wide variety
of its applications and recent promising studies. Based upon the topics discussed throughout this
chapter, we can conclude that POSS is a valuable nano-material and has many advantages to
contribute to the advancement of polymer science and biomedicine.
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Chapter III. Experimental Procedures of Polymer Synthesis, Fabrication,
Characterization, and Cell Studies
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3.1 Introduction
In this study, I synthesized neat PCLF along with a novel series of PCLF-co-POSS
nanohybrid polymeric networks with varied weight fractions of POSS (ϕPOSS = 5%, 10%, and
20%), respectively. Neat PCLF and PCLF-co-POSS nanohybrids were crosslinked into networks
with properties exhibiting low swell ratios and high gel fractions along with tunable mechanical
properties, controlled by manipulating crystallinity and crosslinking density. An advantage of
these polymeric networks is that they are biodegradable, injectable, and can be molded into
various shapes and cured via UV photo-initiation for TE applications. The novel series of PCLFco-POSS nanohybrid networks and pure PCLF were synthesized, characterized, and examined
for their TE viability, by analyzing cell-cell and cell-material interactions. The goal of this
process was to emphasize the ability of neat PCLF and PCLF-co-POSS to enhance adhesion,
proliferation, and growth of mouse pre-osteoblastic MC3T3-E1 cells and primary rat aortic
smooth muscle cells (SMCs) for bone and cardiovascular regeneration. To advance this study,
20% hydroxyapatite (HA) was integrated into the ϕPOSS = 20% polymer network to form PCLFco-POSS/HA; a crosslinked nanocomposite with smooth surfaces and surfaces containing
microgrooves.
3.2 Synthesis and Characterization of PCLF and PCLF-co-POSS
3.2.1 PCLF Synthesis
PCL diols [α,ω-dihydroxy poly(ε-caprolactone)] with a nominal molecular weight of
1250 gmol-1 was purchased from Sigma-Aldrich (Milwaukee, WI) and used for the synthesis of
poly(ε-caprolactone fumarate). PCL diol was dried under vacuum at 50 °C for at least 12 h prior
to the reaction. All other chemicals in this study were purchased from Sigma-Aldrich unless
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otherwise noted. Methylene chloride was dried and distilled over calcium hydride (CaH2) before
the reaction. Fumaryl chloride was purified via distillation at 161 °C. Ground potassium
carbonate (K2CO3) was dried at 100 °C for at least 12 h and then cooled down at vacuum
conditions. PCLF was synthesized via polycondensation of PCL with fumaryl chloride in
methylene chloride with K2CO3 as a proton scavenger [1,2]. PCL diol, fumaryl chloride, and
K2CO3 were measured out in a molar ratio of 1:0.95:1.2. The PCL diol was dissolved in
methylene chloride (1:2v/v) and placed into a 1L three-neck flask along with ground K2CO3. The
mixture was stirred with a magnetic stir bar to form a slurry, to which fumaryl chloride was then
dissolved in methylene chloride (1:1v/v) and added drop wise to the slurry. This reaction
occurred at 50 °C under nitrogen for 12 h.

PCL diol

Fumaryl Chloride

PCLF
Figure 3.1 Synthesis of PCLF
3.2.2 PCLF-co-POSS Synthesis
PCLF-co-POSS was synthesized via polycondensation of PCL diol and POSS with
fumaryl chloride in methylene chloride with K2CO3 as a proton scavenger. 1, 2-Propanediol
isobutyl POSS purchased from Hybrid Plastics (Hattiesburg, MS) was weighed in varied weight
fractions. POSS weight fractions (ϕPOSS = 5%, 10%, and 20% ) were dissolved in methylene
chloride (1:2 v/v) and placed in a 1L three-neck flask. The mixture was stirred with a magnetic
stir bar, to which fumaryl chloride was then dissolved in methylene chloride (1:1v/v) and added
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drop wise. This reaction occurred at 50 °C along with dried ground K2CO3 under nitrogen for 12
h [3].

PCLF-co-POSS

Figure 3.2 Synthesis of PCLF-co-POSS
3.2.3 Fabrication of HA-containing PCLF-co-POSS
PCLF-co-POSS/HA nanocomposites were engineered by incorporating 20% of HA
nanoparticles within the PCLF-co-POSS (ϕPOSS = 20%) network by physical mixing prior to
photo-crosslinking.

Silicon Mold

HA nanoparticles
PCLF-co-POSS network

PCLF-co-POSS/HA

Figure 3.3 Fabrication of Microgrooved PCLF-co-POSS/HA
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3.2.4 Polymer Purification
After polymerizing for 12 h, the mixture was cooled and placed into centrifuge tubes. The
solution was spun down for 12 min at 3000 rpm until the precipitate (K2CO3) was removed. The
supernatant was then added dropwise to petroleum ether to isolate the polymer. Once isolated,
the precipitate was rotary-evaporated then placed under vacuum conditions at 25 °C to remove
traces of organic solvent.
3.2.5 Photo-crosslinking PCLF, PCLF-co-POSS, and PCLF-co-POSS/HA
The photo-initiator, phenyl bis(2,4,6-trimethyl benzoyl) phosphine oxide (BAPO,
IRGACURE 819, Ciba Specialty Chemicals, Tarrytown, NY) was used as a crosslinking agent.
Photo-crosslinking was initiated with a high-intensity long-wave ultraviolet (UV) light (SB100P, λ=365 nm, Intensity: 4800 μw/cm2). In crosslinking, 150 μL of BAPO/CH2Cl2 (300
mg/1.5 mL) solution were mixed with PCLF and PCLF-co-POSS/ CH2Cl2 solution (3 g/1 mL) to
form a homogenous solution [4-6]. PCLF and PCLF-co-POSS solutions were injected into a
mold consisting of two glass plates (2.1mm, thickness) and a Teflon mold to form sheets (10 mm
× 0.5 mm, diameter × thickness) then subjected to UV light at a distance of ~10 cm for 30 min.
To form the PCLF-co-POSS/HA with microgrooves, 20% (600 mg) of HA nanoparticles were
mixed with ϕPOSS = 20%, to which the solution was poured onto a micro-fabricated silicon wafer
(5 μm × 12 μm, groove width × groove depth) between two glass plates (2.1 mm, thickness) and
a silicone spacer (1 mm, thickness). Crosslinked sheets for all samples were removed from the
mold then cooled down to room temperature and cut into strips and disks for experiments.
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UV

PCLF-co-POSS network
PCLF-co-POSS
Figure 3.4 Photo-crosslinking of PCLF-co-POSS.
3.3 Characterization of uncrosslinked and crosslinked PCLF and PCLF-co-POSS
3.3.1 Gel permeation chromatography (GPC)
Gel permeation chromatography (GPC) was performed at room temperature using a GPC
system ( HLC-83200GPC, TOSOH Biosciences LLC., Tokyo, Japan) with a refractive index
indicator to determine the molecular weight and polydispersity index of uncrosslinked PCLF
and PCLF-co-POSS. Tetrahydrofuran (THF) was the eluent and monodisperse polystyrene
samples were used for standard calibration. Cirrus GPC/SEC software (Agilent Technologies,
Santa Clara, CA) was used for data processing.
3.3.2 1H NMR and FTIR
Chemical structure confirmation was determined by using 1H Nuclear Magnetic
Resonance (1H NMR) and was carried out with a Varian Mercury 300 spectrometer (Agilent
Technologies, Santa Clara, CA) using CDCl3 solutions containing tetramethylsilane (TMS).
Fourier Transform Infrared (FTIR) spectra were gathered on a Perkin Elmer Spectrum Spotlight
300 spectrometer with diamond Attenuated Total Reflectance (ATR).
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3.3.3 Gel fraction and swelling ratio
Gel fraction and swelling ratio measurements were performed on PCLF, PCLF-co-POSS,
and PCLF-co-POSS/HA (8 mm × 0.8 mm, diameter × thickness) to determine crosslinking
density. The crosslinked disks were then soaked separately in excess CH2Cl2 and water for two
days then removed and weighed after being blotted quickly. After weighing, the solvent in the
disks was evacuated by vacuum and the dry disks were weighed.
3.3.4 Differential scanning calorimetry (DSC)
Differential Scanning Calorimetry (DSC) was used to determine the melting temperature
(Tm), crystallization temperature (Tc), and crystallinity (Xc). Samples were implemented using a
DSC (TA Q2000, TA Instruments, New Castle, DE) system in a nitrogen atmosphere. To keep a
constant thermal history, the uncrosslinked PCLF and PCLF-co-POSS, and crosslinked PCLF,
PCLF-co-POSS, and PCLF-co-POSS/HA samples were heated from 25° to 100 °C then cooled
to -60 °C at a rate of 10 °C min-1. The subsequent runs were performed at 30 °C and heated to
100 °C at 10 °C min-1 then cooled from 100 ° to -60 °C at the rate of 10 °C min-1. Universal
Analysis 2000 supplied by (TA Instruments) was used for data processing.
3.3.5 Thermogravimetric analysis (TGA)
Thermogravimetric analysis (TGA) was used to determine the thermal degradation of
uncrosslinked PCLF and PCLF-co-POSS, and crosslinked PCLF, PCLF-co-POSS, and PCLFco-POSS/HA samples. Samples were implemented using a TGA (TA Q50, TA Instruments, New
Castle, DE) thermal analyst system in nitrogen conditions at a heating rate of 20 °C min-1 up to
600 °C. Universal Analysis 2000 was used for data processing.
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3.3.6 Dynamic mechanical analysis (DMA)
Dynamic Mechanical Analysis (DMA) was carried out to determine the tensile and
modulus properties of crosslinked PCLF, PCLF-co-POSS, and PCLF-co-POSS/HA specimens.
The samples were cut into strips (10 mm × 1.5 mm × 0.5 mm, length x width x thickness) and
implemented using a dynamic mechanical analyzer (TA Q800, TA Instruments, New Castle, DE)
at 37 °C. Samples were chosen to be elongated up to 200% at a strain rate of 30% min -1.
Universal Analysis 2000 was used for data processing.
3.3.7 Water contact angles
Hydrophobicity was determined by measuring water contact angles at 37 °C using a
Ramé-Hart NRC C. A. goniometer (Model 100-00-230, Mountain Lakes, NJ). Crosslinked PCLF
and PCLF-co-POSS disks (8 mm × 0.5 mm, diameter × thickness) were used in the experiment
to which 1μL of distilled water (pH = 7.0) was injected onto the surface of the disks and the
measurements were taken after a static time of 30 s. To calculate the contact angle in degrees, a
tangent method was used. Three disks were used for four samples to calculate the average and
standard deviation.
3.3.8 Surface topography characterization
Surface topography of ϕPOSS = 20%, PCLF-co-POSS/HA, and microgrooved PCLF-coPOSS/HA were imaged using scanning emission (SEM, Carl Zeiss Auriga, Germany). Samples
were sputter-coated with a gold-palladium layer (Emscope SC 500, Elexience) before imaging.
SEM images were conducted at an accelerating voltage of 2 kV.
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3.4 Cell attachment and proliferation
3.4.1 MC3T3-E1 cells
Mouse MC3T3-E1 pre-osteoblastic cells (CRL-2593, ATCC, Manassas, VA) were used
to determine cell attachment, proliferation, mineralization, and gene expression on PCLF, PCLFco-POSS, and PCLF-co-POSS/HA substrates. The MC3T3-E1 cells were cultured in vitro by
using culture medium consisting of Alpha Minimum Essential Medium (α-MEM; Gibco, Grand
Island, NY), combined with 10% fetal bovine serum (FBS, Sera-Tech, Germany) and 1%
penicillin/streptomycin (Gibco). Culture medium was placed into a polystyrene flask and
MC3T3-E1 cells were plated. Prior to seeding, the cell suspension was then incubated in a 5%
CO2, 95% relative humidity incubator at 37 °C. Subcultures of MC3T3-E1 cells were performed
at approximately 80% confluency. Trypsin with a concentration of 0.025% was used to detach
the cells from the bottom of the polystyrene flask.
3.4.2 Smooth muscle cells
Rat primary SMCs isolated from the aorta were used to examine the ability of PCLF and
PCLF-co-POSS substrates to influence attachment, proliferation, and gene expression. The
SMCs were cultured in vivo similarly to the mouse MC3T3-E1 pre-osteoblastic cells as
described above; however, αMEM was replaced with Dulbecco’s Modified Eagle Medium
(DMEM) as a component of the culture medium.
3.4.3 In vitro cell attachment and proliferation
Prior to seeding, PCLF, PCLF-co-POSS, and PCLF-co-POSS/HA disks (8 mm × 0.5 mm,
diameter × thickness) were dried in a vacuum, pressed between two glass slides to remove
surface inconsistencies, then sterilized in 70% ethanol. The microgrooved PCLF-co-POSS/HA
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samples were not pressed between two glass slides. After sterilization, PCLF and PCLF-coPOSS disks were separately attached onto 48-well tissue culture polystyrene (TCPS) plates with
Silicon-based grease (Dow Corning, Midland, MI) and cleaned with 300 μL of phosphate
buffered saline (PBS, Gibco) prior to seeding. Mouse MC3T3-E1 pre-osteoblastic and rat
primary aortic SMCs were trypsinized, centrifuged at 1000 rpm for 2 min, and collected after
confluency in the culture flask was achieved. MC3T3-E1 cells and SMCs were then separately
seeded onto the polymer substrates at a density of 1.5 × 104 cells/cm2. The negative control was
the empty TCPS well and the positive control was TCPS seeded with cells. The seeded substrates
were then incubated for 4 h to determine cell attachment and 1, 2, 4 days to determine
proliferation. A microplate reader at 490 nm (SpectraMax Plus 384, Molecular Devices,
Sunnyvale, CA) was used to determine the cell numbers obtained from the adsorption values of
the MTS assay, (CellTiter 96 Aqueous One Solution, Promega, Madison, WI) and a standard
curve constructed from known cell numbers. Culture medium was removed from the wells
containing MC3T3-E1cell and SMC seeded substrates and the polymer substrates were washed
twice with PBS after the cells were cultured in a 5% CO 2 and 95% relative humidity atmosphere
at 37 °C for 4 h, 1, 2, 4 days. For fluorescent imaging, the attached cells were fixed in 4%
paraformaldehyde (PFA) solution for 10 min. After fixation, the PFA was removed and PBS was
used to wash the cells twice. Cells were permeabilised with 0.1% Triton X-100 for 10-20 min.
The cytoplasm filaments were stained with rhodamine-phalloidin (RP) and incubated for 1 h at
37°C. After incubating, 4',6-diamidino-2-phenylindole (DAPI) was used to stain the cell nuclei.
MC3T3-E1cell and SMC images were acquired with an Axiovert 25 light microscope (Carl
Zeiss, Germany). Proliferation index (PI) was quantified by dividing the cell number at day 4 by
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the cell number at day 1. Cell area was determined by using ImageJ software (National Institutes
of Health, Bethesda, MD) where averages were taken on 15 non-overlapping cells at day 1.
3.4.4Focal adhesion characterization
MC3T3-E1 cells and SMCs were cultured on PCLF and PCLF-co-POSS disks for 24 h,
washed with PBS, fixed in 4% PFA solution, then permeabilised with 0.1% Triton X-100 for 1 h
at physiological temperature. Cells were then washed with PBS and incubated in 1% bovine
serum albumin (BSA)/PBS for 1 h to reduce background signal. The cells were then treated with
monoclonal mouse antibody against vinculin (1:1000 in PBS; Sigma) overnight. Following
overnight treatment, cells were washed three times with PBS then cultured in an incubator for 2
h with goat anti-mouse IgG secondary antibody (1:200 in PBS; Sigma). Prior to taking images on
a Leica DM6000B fluorescent confocal microscope, the actin filaments of MC3T3-E1 cells were
stained with RP for 1 h. The area and density of the focal adhesions were determined by
averaging 15 non-overlapping cells by using ImageJ. Further, focal adhesions were characterized
on PCLF-co-POSS/HA (smooth and microgrooved) disks with MC3T3-E1 cells by using the
same protocol described above.

3.5 Cell differentiation
3.5.1 ALP activity and calcium content
After culturing MC3T3-E1 cells on PCLF, PCLF-co-POSS, and PCLF-co-POSS/HA
(smooth and microgrooved) disks for 7 and 14 days, the alkaline phosphatase (ALP) activity and
calcium content were determined. Cells were washed with PBS, trypsinized, and centrifuged at
1000 rpm for 4 min. The acquired cell pellet was re-suspended in 1 mL of 0.2% Nonidet P-40
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(American Bioanalytical, Natick, MA) and stirred in an ice bath for 2 min. The cell lysate was
frozen at 20 °C before determining ALP activity and calcium content. To measure the ALP
activity of the cell lysate, a fluorescence-based ALP Detection Kit (St. Louis, MO; Sigma) was
used. 20 μL of cell lysate was added into each well of a 96-well plate and incubated at 65 °C for
20 min. After incubating, 20 μL of dilution buffer, 160 μL of fluorescent assay buffer, and 1μL
of the 10 mM substrate solution provided in the kit were added into each well followed by 4μL
of cell lysate or control enzyme with known concentrations. The absorbance was measured at
340 nm on the microplate reader and the values were quantified using a standard curve
constructed with varied amounts of control enzyme. Calcium content was determined by using
QuantiChrom calcium assay kit (BioAssay Systems, Hayward, CA). 5 μL of cell lysate was
added into each well of a 96-well plate and mixed with 200 μL of working reagent. The samples
were incubated at room temperature for 3 min before measuring the optical density at 620 nm on
the microplate reader. The absolute calcium content was quantified by using a standard curve
with known concentrations [7,8].
3.5.2 MC3T3-E1 Gene Expression
MC3T3-E1 cells were seeded at ~15,000 cells/cm2 on crosslinked PCLF, PCLF-coPOSS, and (smooth and microgrooved) PCLF-co-POSS/HA disks, then cultured for two weeks.
MC3T3-E1 cells were then trypsinized and total RNA was isolated by using RNeasy Mini Kit
(Qiagen, Valencia, CA). mRNA concentrations (ng/μL) were quantified using a Nanodrop 1000
spectrophotometer (Thermo Scientific, Wilmingtion, DE). After isolating mRNA, cDNA was
synthesized by using DyNAmo cDNA synthesis kit (Thermo Scientific). Table 3.1 below shows
the oligonucleotide primers (Invitrogen) used for RT and real-time PCR. Osteopontin (OPN) was
analyzed for the HA-containing PCLF-co-POSS studies. Real-time PCR reactions were
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conducted in 25 μL of PCR mixture containing each cDNA sample and Power SYBR Green
PCR Master Mix (Applied Biosystems, Carlsbad, CA). PCR was carried out on a Peltier Thermo
Cycler (PTC-200, MJ Research, Watham, MA).The PCR amplification protocol was set to thirty
cycles of 30 s at 95 °C (denaturation), 30 s at 55 °C (annealing), and 30s at 72 °C (elongation)
Table 3.1 MC3T3-E1 oligonucleotide primer sequences for real-time PCR.
Gene
Osteocalcin (OCN)

Primer sequence (5'-3'; F: forward; R:
reverse)
F: CAAGTCCCACACAGCAGCTT
R: AAAGCCGAGCTGCCAGAGTT

Osteopontin (OPN)

F: ACACTTTCACTCCAATCGTCC
R: TGCCCTTTCCGTTGTTGTCC

ALP

F: GCCCTCTCCAAGACATATA
R: CCATGATCACGTCGATATCC

GAPDH

F: ACTTTGTCAAGCTCATTTCC
R: TGCAGCGAACTTTATTGATG

3.5.3 SMC Gene Expression
SMCs were seeded at ~15,000 cells/cm2 on crosslinked PCLF and PCLF-co-POSS disks,
and cultured for 4 days. Total RNA for SMCs was isolated and quantified by using the protocol
described above for MC3T3-E1 cells. Similarly, cDNA was synthesized and real-time PCR was
conducted in by using the same experimental procedure for MC3T3-E1 cells. Genes analyzed
were calponin, smoothlin, and GAPDH. The oligonucleotide primers (Invitrogen) for RT and
real-time PCR are shown in Table 3.2.
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Table 3.2 SMC oligonucleotide primers for real-time PCR.
Gene
Calponin

Primer sequence (5'-3'; F: forward; R:
reverse)
F: AGTCTACTCTCTTGGCTCTGGCC
R: CCTGCCTTCTCTCAGCTTCTCAGG

Smoothlin

F: TCGGAGTGCTGGTGAATAC
R: CCCTGTTTCTCTTCCTCTGG

GAPDH

F: TCTTCACCACCATGGAGAA
R: ACTGTGGTCATGAGCCCTT
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Chapter IV. Regulation of Pre-osteoblastic MC3T3-E1 and Smooth Muscle Cells on
Smooth Disks of Photo-crosslinked PCLF and PCLF-co-POSS
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Abstract
Poly(ε-caprolactone fumarate) (PCLF) was copolymerized with polyhedral oligomeric
silsesquioxane (POSS) with varied weight percentages of POSS (ϕPOSS = 0%, 5%, 10%, and
20%), and photo-crosslinked into polymer substrates. PCLF and PCLF-co-POSS (ϕPOSS = 0%,
5%, 10%, and 20%) polymer substrates were characterized for their material properties as well
as, their ability to influence mouse pre-osteoblastic MC3T3-E1 cell and rat primary aortic
smooth muscle cell (SMC) activity. The increase of (ϕPOSS) within the polymer network showed
to increase wettability and significantly improve tensile strength. Further, as (ϕPOSS) was
increased, both MC3T3-E1 and SMC attachment, proliferation, and differentiation were
improved. Studies suggested that the increase in (ϕPOSS) enhanced material properties and cell
favorability for the polymer substrates over neat PCLF.
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4.1 Introduction
In this chapter, four different PCLF-co-POSS (ϕPOSS = 0%, 5%, 10%, and 20%)
injectable, photo-crosslinkable, and degradable nano-hybrid polymer networks were prepared by
the methods described above in Chapter III. All of the substrates involved in this study contained
smooth surfaces without any further modifications. The structural, physical, mechanical, and
thermal properties of all samples were first characterized followed by the analysis of mouse preosteoblastic MC3T3-E1 cell and smooth muscle cell (SMC) activity on the substrates.
Throughout this study, varied compositions of POSS (ϕPOSS) were used to tailor the properties of
the polymer networks to enhance MC3T3-E1 and SMC attachment, proliferation, and
differentiation. Both MC3T3-E1 cells and SMCs were analyzed on their ability to attach,
proliferate, express genes, and display focal adhesions.
4.2 Results and Discussion
4.3 Structural characterizations
The PCLF and PCLF-co-POSS samples were synthesized in the presence of methylene
chloride, fumaryl chloride, and K2CO3, and were opaque to white at room temperature when they
were semi-crystalline. The weight-average (Mw), number-average (Mn), and polydispersity index
(PDI) of PCLF and PCLF-co-POSS were determined using GPC (Table 4.1). By increasing
ϕPOSS, molecular weight increases, which has an impact on the mechanical, crosslinking, and
crystalline properties.
Table 4.1 Molecular Weight Information of PCLF and PCLF-co-POSS.
Sample
PCL diol
PCLF
5%
10%
20%

Mn (gmol-1)
1250
3970
6230
6890
7080

Mw (gmol-1)
2350
5440
7940
10600
10100
74

PDI
1.9
1.4
1.3
1.5
1.4

To confirm the chemical structures of PCLF and PCLF-co-POSS, 1H NMR and FTIR
spectra in Figures 4.1 and 4.2 were used, respectively. The FTIR spectra transmission peaks at
2940 and 2840 cm-1 was due to the methylene (CH2) groups in PCLF. The carbonyl (C=O),
which is a common characteristic of PCLF, can be seen from the strong peaks at 1730 cm-1. The
prominence of the carbonyl peak is due to PCL and the contribution of fumaryl chloride. Peaks
at 1260 and 1300 cm-1 were due to C-H rocking vibration of the fumarate group. Fumarate and
C=C peaks can be seen at 1160 cm-1. Finally, the strong peaks at 1150 cm-1 represent the Si-O-Si
bonds in POSS. In the 1H NMR spectra shown in Figure 4.1, all of the chemical shifts were well
assigned to the protons in the polymer structures. The peak at 6.8 ppm is the characteristic of
fumarate in the samples. Because the chemical shift of fumarate protons was below 7 ppm, the
fumarate group in the copolymer is in the cis-configuration [1]. Peaks labeled 1, 2, and 3
represent the presence of POSS in the copolymer. It can be observed that a more prominent peak
in POSS occurs with an increase in POSS loading.
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Figure 4.1 1H NMR spectra of PCLF, PCLF-co-POSS, and POSS. S = solvent.
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Figure 4.2 FTIR spectra of PCLF, PCLF-co-POSS, and POSS.

4.4 Photo-crosslinking
To determine the degree of crosslinking, gel fraction and swelling ratio experiments were
performed on all samples (Figure 4.3). The gel fraction of a polymer indicates the integrity of the
crosslinked sample whereas; the swelling ratio is a low-cost and effective technique to
characterize polymer networks [2,3]. Higher weight percentages of POSS (ϕPOSS = 10% and 20%)
significantly enhanced crosslinking density over PCLF-co-POSS (ϕPOSS = 5%) and neat PCLF
(Table 4.2). The high crosslinking density was characterized by a high gel fraction and a low
swelling ratio. The gel fraction of the PCLF-co-POSS (ϕPOSS = 20%) sample had an 8% higher
gel fraction and a 26% lower swelling ratio than PCLF alone. Based upon the weight of the
original (Wo), dry (Wd), and fully swollen (Ws) PCLF and PCLF-co-POSS disks, swelling ratios
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and gel fractions were calculated by the equations Γo = Wd/Wo ×100% and So = (Ws-Wd)/Wd
×100%, respectively.
Table 4.2 Gel Fraction and Swelling Ratio values.

a

Sample

Gel Fraction (%)

Swelling Ratio

PCLF

85 ± 0.2

6.7 ± 1

5%

88 ± 0.4

6.6 ± 1

10%

89 ± 0.2

5.7 ± 1

20%

92 ± 0.1

5.3 ± 1

b

100

6.8
6.6

80
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Gel fraction %

6.4
60
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6.2
6.0
5.8
5.6

20

0

5.4
5.2
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PCLF

5%

10%
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Figure 4.3 (a) Gel fractions and (b) swelling ratios of PCLF and PCLF-co-POSS in CH2Cl2.
4.5 Water contact angle
Surface energy and wettability of crosslinked PCLF and PCLF-co-POSS was determined
by performing water contact angle experiments and measurements. The water contact angle
experiment was carried out under physiological conditions (37 °C). Crosslinked PCLF and
PCLF-co-POSS (ϕPOSS = 5%, 10%, and 20%) samples showed water contact angles of 70 ± 4°, 68
± 1°, 67 ± 2°, and 65 ± 4°, respectively. The higher water contact angle on PCLF can be
described by its more hydrophobic nature [4].
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4.6 Mechanical properties
The modulus of elasticity (E) measurement for crosslinked PCLF, and PCLF-co-POSS
was carried out at physiological temperature (37 °C). As evident from Figure 4.4, the covalent
incorporation of POSS in the PCLF network enhanced the modulus of elasticity significantly
from 3.9 ± 0.9 MPa for neat crosslinked PCLF to 5.1 ± 1.1, 6.4 ± 0.7, and 8. 0± 1.4 MPa for
crosslinked PCLF-co-POSS with ϕPOSS = 5%, 10%, and 20% respectively. The increase in the
modulus of elasticity for higher POSS containing copolymers can possibly be explained by the
higher crosslinking density induced from increased POSS loading. Further, elongation was
greatest for neat crosslinked PCLF, while the increase in POSS loading hindered elongation but,
significantly enhanced stiffness as indicated by the steeper slope.
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Figure 4.4 Stress vs strain curves of photo-crosslinked PCLF and PCLF-co-POSS. Inset:
magnification of the slope.
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4.7 Thermal properties
TGA curves in Figure 4.5 were used to determine the thermal stability by examining the
degradation temperature (Td) of uncrosslinked PCLF, PCLF-co-POSS, POSS, and crosslinked
PCLF and PCLF-co-POSS. All of the samples had a single degradation step. Td values of the
uncrosslinked and crosslinked samples are shown in Table 4.3. Td was highest for ϕPOSS = 20%;
however, PCLF-co-POSS samples (ϕPOSS = 10% and 5%) are slightly lower than neat PCLF and
POSS, demonstrating the lowest Td (Table 4.3). Crosslinked samples experienced a higher Td
than the uncrosslinked samples. Similar to the uncrosslinked samples, the crosslinked T d was
highest for ϕPOSS = 20% and PCLF, respectively. As POSS loading increases above ϕPOSS = 10%,
thermal stability is enhanced which is likely due to the ability of POSS to degrade at a lower
temperature than PCLF and protect the surface layer of the polymer matrix by slowing the
diffusion of oxygen [5,6].

Table 4.3 Thermal Properties of PCLF, PCLF-co-POSS and POSS.
Sample
PCLF
5%
10%
20%
POSS

Td (°C)
415 (420)
397 (415)
413 (418)
418 (423)
391

Tm1 (°C)
39.6 (39.5)
35.5 (35.5)
35.1 (37.6)
33.5 (28.4)
-

Tm2 (°C)
45.8
41.9
43.1
42.8
-

Tc (°C)
17.1 (12.9)
15.2 (1.8)
8.0 (2.5)
5.7 (-22.6)
-

∆Hm (J/g)
62.2 (43.3)
47.2 (40.6)
46.5 (32.3)
32.2 (20.7)
-

* Data in parenthesis indicate values of crosslinked PCLF and PCLF-co-POSS.
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Xc (%)
46.1 (30.7)
36.8 (30.3)
38.3 (25.4)
29.8 (18.3)
-
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Figure 4.5 TGA curves of (a) PCLF, PCLF-co-POSS, and POSS and (b) photo- crosslinked
PCLF and PCLF-co-POSS.

DSC curves (Figure 4.6) were used to gather the thermal properties such as melting
temperature (Tm), crystallization temperature (Tc), and heat of fusion (∆Hm), for PCLF, PCLF-coPOSS, POSS, and crosslinked PCLF and PCLF-co-POSS samples. Crystallinity (Xc) for
uncrosslinked and crosslinked samples was calculated by using the equation Xc = [∆Hm/(1ϕPOSS∆Hmc)] × 100% and Xc = [∆Hm/(1-ϕPOSS∆Hmc) × 95.7%] × 100%, where ϕPOSS was 0%, 5%,
10%, and 20%, respectively. The heat of fusion for completely crystalline PCL is 135J/g [7].
Uncrosslinked samples exhibited lower ∆Hm and Xc with higher compositions of POSS in the
copolymer. The increase in Tm relative to higher ϕPOSS for uncrosslinked samples can be
attributed to the high crystalline nature of the POSS monomer with a T m of 172.9 °C [8].
Crosslinked samples exhibited lower ∆Hm, Xc, and Tc than uncrosslinked samples as ϕPOSS was
increased, which was likely because chain motions were suppressed by the crosslinks.
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Figure 4.6 DSC (a) heating curve of PCLF and PCLF-co-POSS (b) photo-crosslinked PCLF and
PCLF-co-POSS. (c) cooling curves of PCLF and PCLF-co-POSS (d) photo-crosslinked PCLF
and PCLF-co-POSS.
4.8 Cell attachment and proliferation
Cell attachment and proliferation studies were performed by using mouse pre-osteoblastic
MC3T3-E1 cells and rat primary aortic smooth muscle cells cultured on PCLF and PCLF-coPOSS disks. The purpose of this experiment was to determine the potential use of crosslinked
PCLF and PCLF-co-POSS as biodegradable and injectable scaffolds to promote orthopedic and
cardiovascular regeneration. The amount of MC3T3-E1 cells and SMCs at days 1, 2, and 4 postseeding on PCLF and PCLF-co-POSS showed similarities with the positive control of tissue
culture polystyrene (TCPS), thereby indicating that the PCLF and PCLF-co-POSS substrates
were non-cytotoxic in the time considered for cell attachment and proliferation studies. All of the
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substrates examined in this study provided necessary microenvironments for MC3T3-E1 cell and
SMC attachment and proliferation, as indicated by the spread-out phenotype (Figures 4.7a and
4.8a).
4.8.1 MC3T3-E1 cells cultured on PCLF and PCLF-co-POSS disks
Mouse pre-osteoblastic MC3T3-E1 cell attachment at 4 h was significantly higher for
PCLF-co-POSS (ϕPOSS = 10% and 20%) than crosslinked PCLF. Crosslinked PCLF-co-POSS
(ϕPOSS = 10% and 20%) cell attachment values resembled similar results to that of the positive
control (TCPS) (Figure 4.7b). The proliferation of MC3T3-E1 cells over a 4 day period (Figure
4.7c) indicated similar results to the trend seen for cell attachment, as proliferation was
significantly enhanced on PCLF-co-POSS (ϕPOSS = 10% and 20%) when compared to crosslinked
PCLF and PCLF-co-POSS with ϕPOSS = 5%. Adding POSS at ϕPOSS of = 5%, 10%, and 20%
enhanced both cell attachment and proliferation greater than crosslinked PCLF alone, therefore
indicating the MC3T3-E1 cell preference for stiffer substrates, which was consistent with recent
literature [9,10]. The proliferation index (PI) of MC3T3-E1 cells (Figure 4.7d) increased from
1.2 ± 0.8 on crosslinked PCLF to 1.6 ± 0.6 on the stiffer PCLF-co-POSS (ϕPOSS = 20%), further
indicating the preference of stiffer substrates for MC3T3-E1 cells.
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Figure 4.7 MC3T3-E1 cell attachment and proliferation. (a) Fluorescent images stained with
rhodamine-phalloidin (red) and DAPI (blue) on crosslinked PCLF and PCLF-co-POSS disks at
days 1, 2, and 4 post-seeding. (b) Normalized cell attachment at 4 h. (c) Cell numbers at days 1,
2, and 4. (d) Proliferation index of MC3T3-E1 cells. (e) MC3T3-E1 cell area at 1 day. *, p < 0.05
relative to PCLF for cell attachment and cell area, and PCLF and ϕPOSS = 5% for cell number and
PI. +, p < 0.05 relative to PCLF for cell number and PI. #, p < 0.05 relative to ϕPOSS = 5% at day
4. Scale bar of 200 μm is applicable to all.
84

4.8.2 SMCs cultured on PCLF and PCLF-co-POSS disks
Rat primary aortic SMCs were also studied on their ability to attach and proliferate on
crosslinked PCLF and PCLF-co-POSS disks. Cell attachment was evaluated at 4 h and showed
similar results to the cell attachment of MC3T3-E1 cells, where cell attachment was significantly
higher for PCLF-co-POSS (ϕPOSS = 10% and 20%) when compared to crosslinked PCLF and
PCLF-co-POSS (ϕPOSS = 5%) (Figure 4.8b). SMCs showed better attachment on all samples
when compared to MC3T3-E1 cells. SMC proliferation was examined over a 4 day period at
days 1, 2, and 4. SMC proliferation was significantly improved on PCLF-co-POSS (ϕPOSS = 20%)
disks when compared to crosslinked PCLF and PCLF-co-POSS (ϕPOSS = 5%) (Figure 4.8c). All
POSS-containing (ϕPOSS = 5%, 10%, and 20%) samples showed better cell attachment and
proliferation than crosslinked PCLF, similarly to the study conducted with MC3T3-E1 cells. The
results shown for SMCs follow a similar trend as discussed for MC3T3-E1 cells and was likely
due to SMCs affinity to attach and proliferate on stiffer substrates [11,12]. The PI of SMCs
(Figure 4.8d) increased from 1.33 ± 0.7 on crosslinked PCLF to 1.7 ± 0.6 on PCLF-co-POSS
(ϕPOSS = 20%); however, the PI for PCLF-co-POSS (ϕPOSS = 10% and 20%) are nearly identical.
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Figure 4.8 SMC cell attachment and proliferation. (a) Fluorescent images stained with
rhodamine-phalloidin (red) and DAPI (blue) on crosslinked PCLF and PCLF-co-POSS disks at
days 1, 2, and 4 post-seeding. (b) Normalized cell attachment at 4 h. (c) Cell numbers at days 1,
2, and 4. (d) Proliferation index of SMCs. (e) SMC cell area at 1 day. *, p < 0.05 relative to
PCLF and ϕPOSS = 5% for all graphs. +, p < 0.05 relative to PCLF at day 4. Scale bar of 200 μm
is applicable to all.
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4.9 Focal adhesions
Focal adhesions (FAs) for both MC3T3-E1 cells and SMCs were analyzed using
fluorescent images. FAs were characterized to determine cell adhesion, as FAs are the closest
contact with regards to cells and the underlying substrate, and act as signal carriers to the
extracellular matrix (ECM) [13,14]. Cytoskeleton F-actin was stained red with RP and vinculinstained green was used to amplify the FA protrusions. FAs were quantified by cell density, i.e.,
FAs per cell, average FA area, and FA elongation, which is the inverse of circularity.
4.9.1 MC3T3-E1 focal adhesions
MC3T3-E1 focal adhesion density was significantly higher on all stiffer POSS-containing
substrates when compared to crosslinked PCLF. The stiffest substrate PCLF-co-POSS (ϕPOSS =
20%) showed to have statistically significant higher FA cell area and elongation when compared
to all other samples, PCLF and PCLF-co-POSS (ϕPOSS = 5%, and 10%). Fluorescent confocal
microscopy images confirmed that FA protrusions are more prominent on the substrates
containing larger POSS fractions, as indicated by the arrows (Figure 4.9).

87

ϕPOSS = 0%

10%

5%

20%

F-actin

a

Vinculin + RP

Vinculin

40 μm

b

c

30 @ day 1

*

20
+

15
10

FA elongation

4

FA area (m2)

Density (FAs/Cell)

*

@ day 1

25

3

2

1

5
0

d

5

0%

5%

10%

20%

POSS

0

0%

5%

POSS

10%

20%

3.4
3.2
3.0
2.8
2.6
2.4
2.2
2.0
1.8
1.6
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0

@ day 1

*

+
+

0%

5%

10%

20%

POSS

Figure 4.9 (a) Fluorescent images of MC3T3-E1 cells stained with RP (red) top row, vinculin
(green) middle row, and RP + vinculin bottom row. (b) FA density. (c) FA area. (d) FA
elongation. *, p < 0.05 relative to PCLF and ϕPOSS = 5% for density and relative to all other
samples for area and elongation. +, p < 0.05 relative to PCLF for all data. Arrows indicate FA
protrusions. Scale bar of 40 μm is applicable to all.
4.9.2 SMC focal adhesions
SMC FAs were characterized and quantified similarly to MC3T3-E1 cells. FA density
was significantly higher on PCLF-co-POSS (ϕPOSS = 10% and 20%) substrates, indicating SMC
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favorability for stiffer substrates (Figure 4.10). As surface stiffness and FA density increases, cell
mechanotransduction mechanisms involving the crosstalk between actin and adhesion
complexes, i.e., FAs, tend to activate integrins during cell attachment [15,16]. Cell area and
elongation was significantly higher for PCLF-co-POSS (ϕPOSS = 20%) when compared to all
other samples. FA protrusions are indicated by the arrows.
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Figure 4.10 (a) Fluorescent images of SMCs stained with RP (red) top row, vinculin (green)
middle row, and RP + vinculin bottom row. (b) FA density. (c) FA area. (d) FA elongation. *, p
< 0.05 relative to PCLF and ϕPOSS = 5% for density and relative to all other samples for area and
elongation. Arrows indicate FA protrusions. Scale bar of 40 μm is applicable to all.
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4.10 Cell differentiation
4.10.1 ALP and calcium content
Early stages of MC3T3-E1 cell differentiation was characterized by examining alkaline
phosphatase (ALP) activity and calcium content, which are two indicators of osteoblast
differentiation. The ALP activity and calcium content was examined after being cultured for 7
and 14 days [17]. ALP activity and calcium content was maximized on PCLF-co-POSS (ϕPOSS =
20%), showing a statistically significant difference when compared to crosslinked PCLF (Figure
4.11). The results indicate that POSS-containing substrates promote greater ALP activity and
calcium content, which was likely due to MC3T3-E1 cells being able to sense POSS after the
proliferative period [14,18]. It should be noted that ALP activity was maximized at week one,
which is because of its role as an early bone marker [19]. Meanwhile, mineralization increased
after one week, as indicated by an increase in calcium content.
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Figure 4.11 ALP activity and calcium content of MC3T3-E1 cells cultured on crosslinked PCLF
and PCLF-co-POSS for (a) 7 days. (b) 14 days. *, p < 0.05 relative to PCLF at 7 days and PCLF
and ϕPOSS = 5% at 14 days. +, p < 0.05 relative to PCLF.
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4.10.2 MC3T3-E1 Gene Expression
Gene expression of MC3T3-E1 cells was analyzed after being cultured on crosslinked
PCLF, and PCLF-co-POSS (ϕPOSS = 5%, 10%, and 20%), for 14 days. Reverse transcriptase (RT)
and real-time PCR were used to quantify ALP and osteocalcin (OCN) expression levels relative
to GAPDH. The ALP gene in MC3T3-E1 cells was used as an early indicator of osteoblast
differentiation since their peak expression level occurred at 7 days [19-21]. OCN expression was
used as a late maker of osteoblastic differentiation, which reached its maximum expression levels
after 14 days. The difference between early and late differentiation markers can explain the
higher expression levels of OCN when compared to ALP. Even though, the differentiation
markers have varied expression levels over time, the dependence upon ϕPOSS was similar (Figure
4.12).
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4.10.2 SMC Gene Expression
SMC gene expression was observed after being cultured on PCLF and PCLF-co-POSS
(ϕPOSS = 5%, 10%, and 20%), for 4 days. Smoothlin and calponin for contractile SMCs were the
gene markers examined. [22,23]. Expression of both smoothlin and calponin relative to GAPDH
showed a similar trend in expression with varied ϕPOSS. Gene expression was significantly higher
on PCLF-co-POSS (ϕPOSS = 10% and 20%) when compared to crosslinked PCLF and PCLF-coPOSS (ϕPOSS = 5%) (Figure 4.13).
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4.10 Conclusions
Novel injectable, photo-crosslinkable, and degradable PCLF-co-POSS nano-hybrid
polymer networks with varied POSS loading (ϕPOSS = 0%, 5%, 10%, and 20%) were synthesized
and photo-crosslinked via UV light. Results showed that the increase of ϕPOSS lead to enhanced
photo-crosslinking, as characterized by the gel fraction and swelling ratio. Further, higher ϕPOSS
resulted in increased stiffness, as indicated by DMA tensile testing. Mouse pre-osteoblastic
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MC3T3-E1 cells and rat primary aortic SMCs favored the stiffer substrates with greater ϕPOSS
fractions, which was evident from increased cell attachment, proliferation, mineralization, and
gene expression. Finally, when comparing the MC3T3-E1 and SMC response on PCLF-co-POSS
substrates, SMCs had a greater affinity for the substrates, as evident by an increased cell number
and proliferation index. This study clearly demonstrated the ability of POSS to improve physical
properties of PCLF networks as well as, enhance the favorability for cell environments.
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Chapter V. Regulation of MC3T3-E1 Cells on Smooth and Microgrooved PCLF-coPOSS/HA Nanocomposite Substrates
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Abstract
Regulation of mouse pre-osteoblastic MC3T3-E1 cells was examined on photo-crosslinked
substrates of poly(ε-caprolactone fumarate) (PCLF) and polyhedral oligomeric silsesquioxane
(POSS), which were copolymerized via polycondensation with a POSS weight fraction of (ϕPOSS
= 20%). To enhance this study further and improve the surface chemistry of the polymer
nanocomposite, PCLF-co-POSS was supplemented with 20% hydroxyapatite (HA). HA was
homogenously integrated into the PCLF-co-POSS network and material properties as well as,
cell behavior were analyzed and compared with PCLF-co-POSS. The addition of HA within the
polymer network resulted in enhanced mechanical properties. To examine the effect of surface
topography, smooth PCLF-co-POSS, PCLF-co-POSS/HA and microgrooved PCLF-coPOSS/HA was studied on its ability to influence cell behavior. The integration of HA showed to
improve mechanical properties and MC3T3-E1 cell behavior as attachment, proliferation,
mineralization, and differentiation were enhanced. Further, microgrooved surface features
significantly improved mineralization and gene expression over substrates with smooth surfaces.
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5.1 Introduction
The purpose of this study was to regulate mouse pre-osteoblastic MC3T3-E1 cell
behavior by incorporating 20% hydroxyapatite (HA) nanoparticles into PCLF-co-POSS (ϕPOSS =
20%) to form photo-crosslinked nanocomposites. MC3T3-E1 cell behavior was examined on
smooth ϕPOSS = 20%, PCLF-co-POSS/HA, and microgrooved PCLF-co-POSS/HA substrates.
Microgroove dimensions that were used measured 5 μm ×12 μm (groove width × groove depth).
Since PCLF-co-POSS (ϕPOSS = 20%) substrates proved to promote cell attachment and
proliferation better than PCLF and PCLF-co-POSS (ϕPOSS = 5%, and 10%), the introduction of
HA into the ϕPOSS = 20% polymer network was thought to further enhance cell behavior (e.g., cell
attachment, proliferation, mineralization, focal adhesions, and gene expression) because of the
prominent role that HA plays in bone composition. In this study physical, mechanical, and
thermal properties of PCLF-co-POSS (ϕPOSS = 20%) and PCLF-co-POSS/HA substrates were
compared along with their ability to influence MC3T3-E1 cell behavior.
5.2 Results and Discussion
5.2.1 Photo-crosslinking
Gel fractions and swelling ratios of PCLF-co-POSS/HA were compared to PCLF-coPOSS (ϕPOSS = 20%) after photo-crosslinking. HA particles were able to suspend in the PCLF-coPOSS solution to ensure homogenous HA distribution in the crosslinked network. PCLF-coPOSS/HA, swelling ratios (S) and gel fractions (Γ) were calculated by the equations, S = [(1ϕHA) × Γo x So]/ [(1- ϕHA) × Γo + ϕHA] and Γ = ϕHA + (1-ϕHA) × Γo, where So and Γo were the
experimental swelling ratio and gel fraction for the pure PCLF-co-POSS network, respectively.
The “theoretical” gel fraction of PCLF-co-POSS/HA differs from PCLF-co-POSS because HA is
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insoluble in CH2Cl2. The addition of HA increased the gel fraction while lowering the swelling
ratio (Figure 5.1) [1]. This result is similar to recent literature regarding the addition of HA into
PCLF networks [1,2]. The addition of HA in the polymer network resulted in a higher gel
fraction since HA particles are insoluble in CH2Cl2.
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Figure 5.1 (a) Gel fractions and (b) swelling ratios of PCLF-co-POSS/HA.

5.2.2 Thermal and Mechanical Properties
Thermal and mechanical properties of PCLF-co-POSS were slightly altered after
introducing HA into the polymer network (Figure 5.2a). The modulus of elasticity (E) was
greater for the HA-containing nanocomposite; however, the incorporation of HA lead to brittle
behavior of the polymer matrix, as evident by reduced elongation [1]. With the incorporation of
HA, osteoconductivity can be enhanced along with material stiffness, to promote a favorable
environment for bone tissue engineering applications [1-4]. Thermal stabilities of PCLF-coPOSS (ϕPOSS = 20%) and PCLF-co-POSS/HA are demonstrated below (Figure 5.2b). Thermal
degradation (Td) of PCLF-co-POSS (ϕPOSS = 20%) and PCLF-co-POSS/HA occurred in a single
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step, where the onset of degradation was at 423 ° and 415 °C for PCLF-co-POSS (ϕPOSS = 20%)
and PCLF-co-POSS/HA, respectively. As indicated in a previous report, HA nanoparticles were
stable at temperatures up to 600 °C [1]. The weight fraction of residue at 600 °C was ~20 for
PCLF-co-POSS/HA, which shows good agreement to the 20% HA weight fraction within the
polymer network. Thermal properties were determined by DSC (Figures 5.2c and 5.2d). Melting
temperature (Tm), crystallization temperature (Tc), and crystallinity (Xc) remained similar (Table
5.1). Xc was calculated by the following equation, Xc = [∆Hm/(ϕPCL ∆Hmc)] × 100%, where ∆Hmc
is the known value of 135 J/g for completely crystalline P CL, and the composition of PCL in the
nanocomposite is ϕPCL = (1-ϕHA) × 97.5% [5].
Table 5.1 Thermal properties of crosslinked ϕPOSS = 20% and PCLF-co-POSS/HA.
Sample
Td (°C) Tm1 (°C) Tc (°C) ∆Hm (J/g) Xc (%)
PCLF-co-POSS
423
28.4
-22.6
20.7
18.3
PCLF-co-POSS/HA 415
29.7
-26.9
15.4
19.7
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Figure 5.2 Thermal and mechanical properties of crosslinked ϕPOSS = 20% and PCLF-coPOSS/HA. (a) Stress vs strain curves (b) TGA curves (c) DSC cooling curves (d) DSC heating
curve.
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5.2.3 Surface topography characterization
Surface topography of PCLF-co-POSS (ϕPOSS = 20%) and smooth/microgrooved PCLFco-POSS/HA samples were imaged using scanning emission microscopy (SEM). Figure 5.3
shows the unique surface characteristics of each sample. The higher gel fraction of the PCLF-coPOSS/HA led to slightly smoother surfaces when compared to PCLF-co-POSS (ϕPOSS = 20%)
[6,7]. Microgrooved PCLF-co-POSS/HA is shown (Figure 5.3c) with a groove width of 5 μm.
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b

a

10 μm

10 μm

10 μm

Figure 5.3 SEM images of (a) ϕPOSS = 20%. (b) smooth PCLF-co-POSS. (c) microgrooved PCLFco-POSS/HA.
5.3 Cell attachment and proliferation
MC3T3-E1 cells were seeded onto crosslinked PCLF-co-POSS (ϕPOSS = 20%), PCLF-coPOSS/HA, and microgrooved PCLF-co-POSS/HA disks. Cell attachment was determined 4 h
post-seeding and cell proliferation was analyzed after 1, 2, and 4 days. Both smooth and
microgrooved PCLF-co-POSS/HA showed greater attachment and proliferation when compared
to PCLF-co-POSS (ϕPOSS = 20%) as shown in Figure 5.4. The proliferation index (PI) increased
from 1.63 ± 0.6 for PCLF-co-POSS (ϕPOSS = 20%) to 1.76 ± 0.8 and 1.76 ± 0.7 for smooth and
microgrooved PCLF-co-POSS/HA, respectively. Microgrooved PCLF-co-POSS/HA influenced
cell behavior as indicated by the vertical alignment. As indicated below (Figure 5.4), cells react
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to different micro/nano topographies through the “contact guidance” effect [8-13]. Elongation of
cells on microgrooved substrates was also observed. Cell alignment and elongation on
microgrooved substrates occurs when cells sense forces thereby, influencing cells to adjust to the
topography of the substrate and maintain optimal force equilibrium [14]. Although cell
alignment was impacted by microgrooves, cell attachment and proliferation was not significantly
influenced [15,16].
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Figure 5.4 MC3T3-E1 cell attachment and proliferation. (a) Fluorescent images stained with
rhodamine-phalloidin (red) and DAPI (blue) on ϕPOSS = 20% and PCLF-co-POSS/HA disks at
days 1, 2, and 4 post-seeding. (b) Normalized cell attachment at 4 h. (c) Cell numbers at days 1,
2, and 4. (d) Proliferation index of MC3T3-E1 cells. (e) MC3T3-E1 cell area at 1 day. *, p < 0.05
relative to ϕPOSS = 20% for cell number at 4 days, PI, and relative to microgrooved PCLF-coPOSS/HA for cell area. Scale bar of 200 μm is applicable to all.
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5.3.1 Focal adhesions
MC3T3-E1 focal adhesions (FAs) on smooth PCLF-co-POSS (ϕPOSS = 20%), PCLF-coPOSS/HA, and microgroved PCLF-co-POSS/HA were examined via confocal microscopy after
being cultured for 1 day. FAs are complex macromolecule complexes which serve to physically
anchor the actin cytoskeleton to integrins that interact with the surrounding extracellular matrix
(ECM) [17]. FA density and elongation on both smooth and microgrooved PCLF-co-POSS/HA
nanocomposites showed to have a statistically significant increase when compared to PCLF-coPOSS (ϕPOSS = 20%), shown in Figure 5.5. Because PCLF-co-POSS/HA had higher mechanical
properties and a more favorable surface chemistry, FA expression was increased [18]. FA
elongation was significantly higher on microgrooved substrates, as they tend to attach to grooves
or ridges in an oriented fashion [18-20].
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Figure 5.5 (a) Fluorescent images of MC3T3-E1 cells stained with RP (red) top row, vinculin
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5.4 ALP activity and calcium content
Mineralization of MC3T3-E1 cells cultured for 7 and 14 days on PCLF-co-POSS (ϕPOSS
= 20%) and (smooth and microgrooved) PCLF-co-POSS/HA was determined by examining
alkaline phosphatase (ALP) activity and calcium content, which are two indicators of
osteoblastic differentiation [21,22]. The surface topography used here was smooth for PCLF-coPOSS (ϕPOSS = 20%) and PCLF-co-POSS/HA, along with a microgrooved PCLF-co-POSS/HA
substrate with a groove width of 5 μm and a groove depth of 12 μm. Both ALP activity and
calcium content were significantly higher on the HA-containing substrates, which can be
attributed to the favorable surface chemistry and mechanical properties induced from HA
incorporation [2]. Further, microgrooved PCLF-co-POSS/HA substrates demonstrated higher
ALP activity and calcium content over smooth PCLF-co-POSS (ϕPOSS = 20%) and PCLF-coPOSS/HA (Figure 5.6). Enhanced mineralization on microgrooves suggested that cell alignment
and confinement within the channels induces early differentiation and complements cell-cell
interactions with the underlying substrate [2,23,24]. Alignment of osteoblasts has shown to alter
cellular functions via altered regulation of cytoskeletal components, which explains the increase
in mineralization and subsequent bone deposition [23-25].
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Figure 5.6 ALP activity and calcium content of MC3T3-E1 cells cultured on crosslinked ϕPOSS =
20%, PCLF-co-POSS/HA and microgrooved PCLF-co-POSS/HA for (a) 7 days. (b) 14 days. *, p
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5.5 Gene expression
Gene expression of MC3T3-E1 cells was determined after being cultured for 14 days on
smooth PCLF-co-POSS (ϕPOSS =20%), PCLF-co-POSS/HA, and microgrooved PCLF-coPOSS/HA. Differentiation gene markers osteocalcin (OCN) and osteopontin (OPN) were
quantified as indicators of osteoblastic maturation and mineralization [2,25]. mRNA expression
of bone differentiation markers shown are relative to GAPDH (Figure 5.7). Since MC3T3-E1
cells were cultured for 14 days, both OCN and OPN were analyzed, as they are late
differentiation gene markers which reach their maximum levels and continue to grow into the
mineralization stage [26]. Gene expression here showed a similar trend to ALP activity and
calcium content dependence upon HA-containing and microgrooved substrates. Microgrooved
PCLF-co-POSS/HA samples showed to upregulate gene expression levels for OCN and OPN
greater than the smooth PCLF-co-POSS (ϕPOSS = 20%) and PCLF-co-POSS/HA. It is likely that
microgrooves are capable of providing a favorable microenvironment for cells by allowing for
better alignment and deformation of nuclei, thereby resulting in altered positioning of
chromosomes and probability of gene expression [2,24-28]. Specifically, greater OCN
expression can be achieved by constraining the nuclear shape of osteoblasts, induced from
alignment [29]
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Figure 5.7 MC3T3-E1 gene expression levels relative to GAPDH at 14 days. OPN expression
POSS = 0%
(white). OCN expression (gray). *, p < 0.05 relative to ϕPOSS = 20% for OPN and all samples for
0%
5%
10%
OCN.
5.6 Further discussion
By enhancing surface chemistry and topography, cellular fate can be tuned to achieve
favorable bone regeneration. Overall, the stiffer substrates containing HA nanoparticles
improved MC3T3-E1 cell attachment, proliferation, and gene expression over PCLF-co-POSS
substrates. Crosslinked and microgrooved PCLF-co-POSS/HA substrates substantially improved
mineralization of MC3T3-E1 cells relative to smooth substrates. Although microgrooves had
minimal impact on cell proliferation relative to smooth surfaces, cell orientation was changed,
causing cells to align in the corresponding direction of the microgrooves. Microgrooved PCLFco-POSS/HA induced nuclei and focal adhesion distortion, as indicated by increased elongation.
Elongation and alignment are important factors to consider, as aligned osteoblasts have the
ability to promote the development of functional cell polarity thereby, favoring mineralization
and bone formation [23]. Recent studies have quantified the aspect ratio of surface features by
dividing groove depth by groove width, to study human dermal fibroblast alignment and
proliferation [30]. Literature suggested that cell alignment can be better achieved with a higher
110

aspect ratio [30]. In this chapter, results suggested that MC3T3-E1 cells alignment responded
well on deeper and narrower grooves (5 μm × 12 μm, groove width × groove depth). The results
have suggested that substrates with tunable surface chemistry and topography can achieve
desirable effects for bone remodeling and regeneration.
5.7 Conclusions
Here PCLF-co-POSS (ϕPOSS = 20%) along with smooth and microgrooved PCLF-coPOSS/HA nanocomposites were fabricated and evaluated on their abilities to regulate mouse preosteoblastic MC3T3-E1 cell behavior. Characterization of the nanocomposites revealed that the
homogenously dispersed HA nanoparticles within the PCLF-co-POSS network increased gel
fraction and stiffness. The increase in stiffness and improvement in surface chemistry induced by
the incorporation of HA showed to improve MC3T3-E1 favorability for the polymer substrates,
as cell attachment, proliferation, and differentiation was enhanced. It was also evident that
microgrooved PCLF-co-POSS/HA substrates upregulated MC3T3-E1 mineralization and gene
expression, which are good indicators of osteogenesis. This study displayed how surface
chemistry and topography can influence cell behavior for orthopedic tissue engineering
applications.
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Chapter VI. Summary
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A series of biodegradable, injectable, and photo-crosslinkable nano-hybrid polymer
composite networks were developed for bone and cardiovascular tissue engineering (TE)
applications. With the increase in demand to repair diseased and injured tissue, polymers have
emerged in the field of regenerative medicine to improve current treatment options, and therefore
offer options to reduce invasive surgical procedures.
In the first study, poly (ε-caprolactone fumarate) (PCLF) was synthesized via
polycondensation. PCLF was then copolymerized with 1,2-propanediol isobutyl POSS in varied
weight fractions (ϕPOSS = 5%, 10%, and 20%) to form the copolymer PCLF-co-POSS. Physical
properties of PCLF and PCLF-co-POSS were examined, and data revealed that the increase in
POSS content lead to enhanced crosslinking density and material stiffness, as indicated by higher
gel fractions and modulus of elasticity, respectively. Thermal properties were also examined, and
results suggested that POSS had the ability to improve the thermal stability of the polymer
network. After physical and thermal characterization, crosslinked PCLF and PCLF-co-POSS
substrates were evaluated on their ability to regulate mouse pre-osteoblastic MC3T3-E1 cells and
rat primary aortic smooth muscle cells (SMCs). The cell studies conducted aimed to evaluate
MC3T3-E1 cell and SMC attachment, proliferation, and differentiation. Throughout the study, it
was found that cell behavior was regulated upon the dependence of ϕPOSS. The increased weight
fractions of ϕPOSS showed to increase cell numbers, mineralization, and gene expression, all of
which are indicators of osteogenesis. Further, SMCs studies showed similar results, as the
increase in ϕPOSS also promoted cell attachment, proliferation, and gene expression. Both PCLF
and PCLF-co-POSS samples showed to effect cell attachment and proliferation similarly to the
tissue culture polystyrene (TCPS), thereby suggesting that cytotoxicity to cells was negligible.
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In the proceeding study, hydroxyapatite (HA) nanoparticles were homogenously
implemented into the PCLF-co-POSS (ϕPOSS = 20%) network to enhance surface chemistry for
bone TE applications. Three samples were developed including, PCLF-co-POSS (smooth and
microgrooved) and PCLF-co-POSS/HA. Both physical and thermal characteristics of the
polymer nanocomposites were analyzed. The addition of HA into the polymer network increased
gel fractions and lowered swelling ratios, which was likely because HA nanoparticles are
insoluble in CH2Cl2. Mechanical properties were altered by the HA nanoparticles, as the polymer
network exhibited a more brittle behavior and the modulus of elasticity was increased over
PCLF-co-POSS (ϕPOSS = 20%). Scanning emission microscopy (SEM) was used to confirm the
surface topography of the PCLF-co-POSS (smooth and microgrooved) and PCLF-co-POSS/HA
substrates. SEM revealed the dimensions of the microgrooved surface with a 5 μm groove width
and 12 μm groove depth. MC3T3-E1 cell attachment, proliferation, and differentiation was
examined to evaluate the effects that surface chemistry and topography plays on regulating cell
behavior. Cell attachment and proliferation was slightly enhanced on PCLF-co-POSS/HA, which
was because of the enhanced surface chemistry rather than surface topography. Surfaces
containing microgrooves changed the orientation of cells and promoted cell alignment via
“contact guidance”. Further, microgrooved surfaces showed to increase mineralization and gene
expression over both smooth PCLF-co-POSS and PCLF-co-POSS/HA substrates.
In summary, I developed a series of novel biodegradable polymer composite networks
with tailorable mechanical, thermal, chemical, and topographical properties for regulating
cellular behavior. The studies conducted showed to promote favorable microenvironments for
bone and smooth muscle cells, therefore indicating their uses for various TE applications.
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